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Introduction
1.1 Ether-à-go-go voltage-gated potassium chan-
nels
Ether-à-go-go (EAG or KCNH) channels are non-inactivating voltage-gated K+
channels that are characterized by delayed-rectifier type currents with activation
thresholds close to the membrane resting potential of most excitable cells (∼ -40
mV for hEAG1 and -80 mV for hEAG2). They are thought to play a role in the
regulation of neuronal excitability [8, 21,31] and in oncogenesis [59].
1.1.1 The eag phenotype and the Drosophila EAG chan-
nel
The EAG gene owes its name to the phenotype of mutant Drosophila melanogaster
which displayed rapid shaking of legs following etherization [31]. This behaviour
was immediately associated with a change in neuronal excitabilty causing “over-
stimulation of the muscles controlling shaking or the removal of a normally present
inhibitory influence” [31]. Work by Ganetzky and Wu [21] linked the eag muta-
tion to TEA-sensitive potassium currents in the Drosophila neuromuscular junction
and reinstated the hypothesis that these currents play a role in maintaining normal
neuronal excitability. The eag locus was found to encode a polypeptide with sim-
ilarities to voltage-gated ion channels [88] and Brüggemann et al. [8] showed that
EAG encodes a novel voltage-gated ion channel that is permeable for potassium and
calcium and modulated by cAMP.
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1.1.2 Mammalian EAG channels
Ludwig et al. cloned the rat homologue of eag (rEAG1) based on sequence similari-
ties with the Drosophila channel [38], 61% of the aminoacid sequence of the channel
was identical across both species, in particular in the regions of the N-terminus and
trans-membrane domains (Fig.1.1). However, several properties of rEAG1 currents
differed from those of the Drosophila channel [38]. Mammalian EAG1 channels do
not mediate inward Ca2+ currents and their activation kinetics had an increased de-
pendency on the membrane holding potential. Moreover, mamalian channels were
not regulated by cyclic nucleotides, whereas in Drosophila application of cAMP
caused a significant increase in outward current amplitudes [8]. The subsequently
cloned mouse and human EAG1 [55, 62], rEAG2 [39] and hEAG2 [28] share these
electrophysiological charcteristics to a large extent, although the EAG2 isoforms
have much lower activation thresholds (∼ -80 mV) and slower activation. A defining
characteristic of EAG currents is the strong dependence of their activation kinetcs on
the holding potential (Cole-Moore effect [15]). Hyperpolarization slows the the acti-
vation of the channel, whereas depolarization accelerates it. This effect is enhanced
by the presence of Mg2+ in the extracellular medium [78].
EAG channels are the founding members of the the KCNH or Ether-à-go-go re-
lated family of voltage-gated K+ channels [89] which currently comprises eight
members (Table 1.1), classified under three subfamilies: EAG, ERG (EAG Related
Gene) and ELK (EAG Like). EAG-family channels are structurally characterized
by the presence of the highly conserved EAG or PAS (Per-Arnt-Sim) domain in
their N-termini [10]. Their currents, however, can differ significantly from those of
EAG.
Table 1.1 The KCNH (eag-related) family of human genes
Gene name IUPHAR channel name Other gene names Chrom. location
KCNH1 Kv10.1 heag1, ether-à-go-go 1q32.1 - 32.3
KCNH2 Kv11.1 herg1, ether-à-go-go related 7q35-36
KCNH3 Kv12.2 helk2, ether-à-go-go like 12q13
KCNH4 Kv12.3 helk3, ether-à-go-go like 17q21.31
KCNH5 Kv10.2 heag2, ether-à-go-go 14q24.3
KCNH6 Kv11.2 herg2, ether-à-go-go related 17
KCNH7 Kv11.3 herg3, ether-à-go-go related 2q24.3
KCNH8 Kv12.1 helk1, ether-à-go-go like 3p24.3
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Expression
Rat EAG channels are expressed exclusively in the brain [38, 39, 59]. In-situ hy-
bridization studies [39, 66] have detected rEAG1 transcripts predominantly in the
hippocampus, cerebral cortex, olfactory bulb and granular layer of the cerebellum of
adult rats. rEAG2 is present the hippocampus, cerebral cortex and thalamus, but
only to a small extent in the cerebellum. In rat hippocampal cultures EAG1 was
found to be present in glutamatergic post-synapses, whereas EAG2 was localized in
GABAergic post-synapses [25].
Structural characteristics
Functional EAG channels are tetramers but, unlike most voltage-gated K+ channels,
the domain mediating the tetramerization of EAG (Tetramerizing Coiled Coil or
TCC domain) is located at the C-terminus of the channel subunits [26,37]. hEAG1
and hEAG2 have been shown to form functional heterotetramers upon co-expression,
resulting in heteromeric channels where the slow activation kinetics of hEAG2 are
dominant [69].
EAG channel subunits are multipass membrane proteins with six trans-membrane
segments (S1-S6) and intracellular tails at the N- and C-termini, a standard topology
which is shared by other voltage-gated K+ channels [88, 89]. The voltage sensor is
located in the positively-charged S4 domain, whereas the channel pore is lined by
transmembrane segments S5 and S6.
The cytosolic N-terminus of EAG contains a Per-Arnt-Sim (PAS) domain followed
by a PAC sequence (PAS-associated C-terminal), which is commonly present at the
C-terminus of PAS domains [98]. PAS domains are conserved structural motifs which
are thought to have a chemosensing and signal transduction function [86, 98]. The
function of the PAS domain in EAG-family channels is not entirely clear, although it
has been suggested that it may play a role in channel gating by binding to the S4-S5
intracellular loop [10, 77]. The extracellular S5-S6 loop contains two asparagine-
linked glycosylation sites (N388, N406), which have been shown to be necessary for
correct membrane expression and channel function [52].
The cytoplasmic region downstream of S6 comprises approximately 50% of the
aminoacid sequence of EAG channels and contains three known regulatory do-
mains - a cyclic nucleotide (cNMP) binding domain [89], a CaM binding domain
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Figure 1.1: Scheme of hEAG1 membrane topology, including known functional domains
and structural features.
(CaMbd) [70] and a Tetramerizing Coiled Coil (TCC). A three aminoacid endoplas-
matic reticulum (ER) retention signal (675RKR677) is thought to prevent channel
trafficking prior to correct assembly [26,33].
Although it contains a segment with substantial similarities to the cNMP binding
domain of cyclic nucleotide gated (CNG) channels, mammalian EAG is not mod-
ulated by cyclic nucleotides [38], unlike its Drosophila homologue [8]. This cNMP
binding motif appears therefore to be non-functional.
1.1.3 Regulation of EAG by Ca2+/CaM
rEAG1 was found to be inhibited by intracellular Ca2+ with a half-maximal in-
hibition of ∼ 100 nM [74]. This inhibition is mediated by the direct binding of
Calmodulin (CaM), a Ca2+-binding protein, to the C-terminus (aa. 707-726) of the
channel [70]. CaM binds hEAG1 only in its Ca2+-bound form, in contrast with other
potassium channels where CaM is a constitutive channel subunit [67]. The binding
of one CaM molecule was found to be sufficient for Ca2+-induced channel closure to
occur [70].
Interestingly, Drosophila EAG currents are enhanced by Ca2+/CaM KinaseII
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(CaMKII) phosphorylation [87], which implies that Ca2+ is exerting opposing ef-
fects in mammalian and Drosophila EAG.
The Ca2+ regulation of ion channels provides a link between intracellular signaling
pathways and membrane electrical activity that can play a role in regulating Ca2+
levels, neuronal excitability and synaptic release. Other K+ channels are known
to be modulated by Ca2+/CaM, namely Ca2+-activated K+ channels (IK and SK),
CNG and KCNQ channels [67].
CaM binding domains and regulation of ion channels
Calmodulin is a small (148 aa., 17 kDa), soluble Ca2+-binding protein that is highly
conserved in eukaryotes. It is extremely abundant, with predominance in the brain
where it can account for 0.5% of all proteins and reach concentrations of 1-10 µM
[67,80]. Intracellularly, CaM is present throughout the cytosol and nucleus [16] but
concentrates mostly in the regions adjacent to the plasma membrane [67].
Structurally, CaM is a monomer with two pairs of Ca2+-binding EF-hand domains
forming two lobes at opposing ends of the protein [2]. Isolated CaM binds Ca2+
with a dissociation constant (Kd) of approximately 5 · 10−6 M but its affinity can
be much higher when in complex with an enzyme [29, 67]. Upon binding of Ca2+
a hydrophobic interaction sites are exposed in each lobe. Ca2+-dependent binding
occurs through hydrophobic interactions and salt bridges, the two lobes of CaM
encircling the target binding site [43]. CaM binding domains are therefore frequently
amphipathic alpha-helices with a positively charged hydrophilic side [67].
Although there is no consensus sequence for CaM binding domains, most target
peptides can be classified as containing one of three motifs [60]:
• IQ motifs - bind CaM independently of Ca2+. Present in some ion channels
which constitutively bind CaM, such as the L-type Ca2+ channel. CaM binding
domains with similarities to the IQ motif are present in IK and SK channels,
which also bind CaM constitutively [67]. The CaM binding domain in the
C-terminus of EAG has significant similarities to the latter, although it binds
CaM only in its Ca2+-bound form [70].
• 1-8-14 motifs - bind CaM in its Ca2+-bound state. Their name refers to the
position of conserved hydrophobic aminoacids in an amphipathic helix struc-
ture. 1-8-14 motifs tend to have a high affinity for Ca2+/CaM. Present e.g. in
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CNG channels [67]
• 1-5-10 motifs - similar to 1-8-14, bind CaM in its Ca2+-bound state. These
motifs are present e.g. in NMDA receptors
1.2 Fluorescence Resonance Energy Transfer
(FRET)
FRET is the term used to describe the non-radiative transfer of energy between
two fluorophores (termed ‘acceptor’ and ‘donor’ molecule) in close vicinity [20].
In its applications for biological assays, two molecules of interest are labelled with
fluorescent molecules with overlaying emission and absorption spectra. FRET can be
detected only when the labelled molecules come within a very short distance of each
other - typically ∼ 5 nm, thus implying that the two molecules are interacting.
Fluorescence
Fluroescence is a property of chemical species (fluorophores) that have photoex-
citable electrons and are able to re-emit a light photon in a time scale of the order
of nanoseconds.
Photoexcitable electrons in fluorescent molecules (usually singlet π electrons) are
excited into a higher energy level by the electric field component of incoming elec-
tromagnetic radiation.
When the electron decays back to the ground state a photon is emited. This photon
has lower energy than the excitation photon - a part of the absorbed energy is
converted internally in the molecule as the excitable electron drops to degenerate
vibrational and rotational energy states. This difference between absorption and
emission spectra is called Stokes’ shift.
Decay into the ground state is not the only possibility for excited electrons. The
increase in bond energy can trigger a chemical reaction, such as oxydation, which
would destroy the fluorophore - this process is called photobleaching. A second
possibility is the transfer of energy to another fluorophore by FRET.
The average time span between absorption and emission is called the fluorescence
lifetime of the fluorophore and can be calculated from the rates of radiative decay
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Mathematical formalism for FRET
The energy transfer efficiency (E) between an excited donor and an acceptor
molecule is strongly dependent on distance, as can be inferred from the mathe-






Where r is the separation between donor and acceptor and R0 is the distance at
which the energy transfer efficiency is 50%, i.e. the rate of transfer is equal to the










• κ is a term describing the relative orientation of the fluorophore dipoles. When
the orientation is the same, energy transfer is optimal. Perperdicular orienta-
tions do not result in energy transfer.
• QD is the ‘quantum efficiency’ of the donor molecule (Qd = Γ/(Γ + Knr)
• n is the refractive index of the medium.
• N is Avogadro’s number
• The integral to the right describes the spectrum overlap between acceptor and
donor fluorophores. The energy accepted must be in the same range as the
energy donated - must therefore choose fluorophores with emission (donor)
and excitation (acceptor) spectral overlap.
The requirement for spectral overlap leads to difficulties in the detection of FRET.
Overlapping spectra usually mean that the acceptor molecule will also be mildly ex-
cited by the donor excitation light and that the emission of the donor will extend into
the emission spectra of the acceptor. Detecting the sensitized (non-photoexcited)
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emission of the acceptor is therefore not an ideal method for detecting FRET, unless
spectral fingerprinting techniques are used for determining the individual emissions
of donor and acceptor fluorophores [53, 54,100].
Other effects of FRET can be used for estimating FRET efficiencies, namely
• The decrease in intensity of the donor
• Decrease of donor lifetime
• Decrease in anisotropy (polarization) of emitted donor light
• Delayed photobleaching dynamics
Measurement of FRET by acceptor photobleaching
Acceptor photobleaching [4] is a technically simple and widely used method to es-
timate energy transfer efficiencies (E) based on the decrease in donor intensity due
to FRET. In acceptor photobleaching measurements the intensity of donor fluores-
cence is recorded in a sample with both donor and acceptor molecules, and the same
measurement is repeated after the destruction of the acceptor by photobleaching.
The difference between donor fluorescence before and after photobleaching is then
normalized to the intensity of the donor after photobleaching in order to calculate





1.2.1 Use of genetically encoded Fluorescent Proteins in
FRET assays
The availability of different genetically encoded Fluorescent Proteins (FPs) has rad-
ically broadened the applications of FRET over last decade (see [9] for a review).
The first reports of FRET between FPs used the Blue Fluorescent Protein (BFP)
as donor and GFP as acceptor [45]. However, BFP suffered from low molar extinc-
tion coefficient, low quantum yield and high susceptibility for photobleaching. CFP
proved to be superior in the latter two aspects and was therefore quickly adopted as
a FRET donor with YFP as acceptor [46]. This is currently the most widely used
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genetically encoded FRET pair, although usually in the form of the brighter and
faster maturing variants Cerulean [61] and Venus [51].
Nevertheless, CFP-YFP is not an optimal FRET pair. There is significant overlap of
the emission spectra of both fluorophores [9] and this problem is exacerbated by the
low absorbance and quantum yield of CFP/Cerulean which results in YFP/Venus
being up to 5 times brighter than the cyan donor [61]. Furthermore, the 430 nm
lasers needed for optimal excitation of CFP are not yet widely available, which ag-
gravates the brightness problem. Additionally, CFP has its emission maximum in a
spectral region with high autofluorescence from cellular components [6]. Several at-
tempts have been made at developing new genetically encoded FRET pairs, however,
most of the FPs proposed so far have disadvantages in comparison to CFP-YFP.
Most notably, red fluorescent proteins, which could serve as acceptors for GFP, have
been plagued with problems such as slow chromophore maturation [84], tetramer-
ization [13], and low photostability [71]. Therefore, CFP/Cerulean - YFP/Venus
remains the FRET pair of choice for most biological applications.
1.3 Aims of this work
EAG1 channels were found to be inhibited by Ca2+/CaM at concentrations close
to the resting Ca2+ levels of neurons [70], a feature which can have far-reaching
implications for their proposed function as regulators of neuronal excitability.
The present work aims at:
Gaining a better understanding of the molecular mechanism of EAG in-
hibition by Ca2+/CaM. A FRET assay for the binding of CaM to the channel
is to be established.
Investigating the sub-cellular localization of EAG in neurons. And its
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Adjust pH to 7.4
4% Formaldehyde (FA)
Continued on next page
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Table 2.1 – continued from previous page
Solution Component Concentration
Formaldehyde 4% (w/v) in PBS
Adjust pH to 7.4 and store at -20◦C
100 mM Glycine in PBS (Quench Buffer)
Glycine 100 mM in PBS
Prepare fresh for each experiment
0.1% Triton X-100 in PBS (Permeabilization Buffer)
Triton X-100 0.1% (v/v) in PBS
0.2% Gelatine in PBS (Wash and Incubation Buffer)
Gelatine (microbiology grade) 0.2% (w/v) in PBS
Prepare fresh for each experiment
Mowiol (Mounting Medium)
Mowiol 4-88 0.1% (w/v)
Glycerol (98%) 25% (v/v)
TRIS pH 8.5 100 mM
Store at -20◦C
TRIS Buffered Saline (TBS)
NaCl 140 mM
TRIS-HCl pH 7.4 200 mM
Adjust pH to 7.4
TBS-T
Tween-20 0.1% in TBS
Table 2.1: Solutions
2.1.2 Synthetic oligonucleotide primers
All DNA primers used in this work are listed in Table 2.2. For primers used in mu-
tagenesis PCR reactions the mutant base pairs are denoted by the use of uppercase
letters.








fw cam mut h ccggcgcctcTCCcagagaTCCcgacagcagaaagagg
rv cam mut h cctctttctgctgtcgGGAtctctgGGAgaggcgccgg
fw cam mut r caggaggctcTCCcaaaggTCCcgccagcagaaagaag
Continued on next page
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Table 2.2 – continued from previous page
Primer name Sequence (5′ → 3′)













fw NtermMut2 h ggctgggggaagtCtTctcggctgacaagagc
rv NtermMut2 h gctcttgtcagccgagAaGacttcccccagcc
NtermNotI-rv atagtttagcggccgctgtggtcttaaagacacag
vencam-fw ctactagctagcatggtgagcaagggcgag
Table 2.2: Oligonucleotide primers
2.1.3 Plasmids
• pcDNA3 Invitrogen
• pGEX-4T-1 Amersham Pharmacia Biotech
• C-Cerulean-pcDNA3 Same as pcDNA3 but with the DNA encoding for the
Cerulean fluorescent protein [61] cloned between NotI restriction sites at the
3′ end of the multiple cloning site.
• pCB6-C-GFP Mammalian expression vector (CMV promoter). This plas-
mid is a gift of Dr. M. Way (CRUK, London, UK) [49]. It is used to make
C-terminus GFP-fusion constructs. GFP is flanked by NotI and BamHI re-
striction sites.
• pCB6-N-YFP Similar to pCB6-C-GFP but designed to make N-terminus
YFP-fusion constructs of the gene of interest. YFP is flanked by KpnI and
NotI restriction sites.
• pMH4-I-SYN Mammalian expression vector (human Synapsin promoter).
This plasmid is a gift of Dr. S. Kügler (U.K.G., Göttingen). The Synapsin
promoter enables selective expression in neuronal cells [32].
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2.1.4 Antibodies
Antigen Host Type Provider Concentration
Neuronal Markers
βtubulin III Mouse Monoclonal Sigma (T8660) 1:200
MAP2 Mouse Monoclonal Sigma (M4403) 1:500
p38 (Synaptophysin) Mouse Monoclonal Sigma (S5768) 1:2000
Calmodulin
Calmodulin Mouse Monoclonal Upstate (#05-173) 1:100
EAG
rEAG1 (7194) Rabbit Polyclonal see §2.2.6 ∼3 µg/ml
rEAG2 (7205) Rabbit Polyclonal see §2.2.6 ∼3 µg/ml
Fluorophore-coupled secondary antibodies
Rabbit IgG (H+L) Goat FITC-conj. Jackson (111095003) 1:5500
Rabbit IgG (H+L) Goat Cy3-conj. Jackson (111165003) 1:5000
Mouse IgG (H+L) Goat Cy5-conj. Jackson (115175003) 1:3500
Table 2.3: Antibodies
2.2 Methods
2.2.1 Plasmid construction and mutagenesis
The following subsections describe the origin or cloning procedure of the cDNA
constructs used in this work. Whenever the Polymerase Chain Reaction (PCR) was
used in the cloning process, the fidelity of the resulting constructs was verified by
DNA sequencing (MPI for Experimental Medicine, DNA core-facility).
hEAG1-Cerulean
The C-terminal Cerulean-fusion construct of full-length hEAG1 was cloned from
CB6-hEAG1-GFP (C-terminal GFP-fusion construct. E. Herrero, G. Bunt).
Cerulean [61] was amplified by PCR with flanking NotI and BamHI sites (primers
2325, 2326) and subsequently cloned in place of GFP into the CB6-hEAG1 vec-
tor [7, 49].
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rEAG1-GFP/rEAG1-Cerulean and rEAG2-GFP/rEAG2-Cerulean
The C-terminal GFP-fusion constructs of full-length rEAG1 and rEAG2 (pcDNA3-
rEAG1-GFP, pcDNA3-rEAG2-GFP) were obtained from M. Ninkovic and G. Bunt.
In order to generate the cyan fluorescent fusion constructs, Cerulean [61] was ampli-
fied by PCR with flanking NotI sites at both ends (primers 2182, 2183) and cloned
in place of GFP into the pcDNA3-rEAG1 and pcDNA3-rEAG2 vectors.
The neuronal-expression, GFP-fusion construct of rEAG1 (pMH4-I-SYN-rEAG1-
GFP) was cloned by J. Uhlendorf and G.Bunt. In order to generate a cyan fluores-
cent fusion construct of rEAG1 under the control of the synapsin promoter (hSyn
rEAG1-Cerulean), Cerulean [61] was amplified by PCR with flanking NotI sites at
both ends (primers 2182, 2183) and cloned in place of GFP into the pMH4-I-SYN-
rEAG1 vector.
Cterm-Cerulean
The Cerulean- and Venus- fusion constructs of the C-terminus (M478-S962) of
rEAG1 was cloned from pcDNA3-Cterm-rEAG1-GFP (C-terminal GFP-fusion con-
struct. M. Ninkovic, G.Bunt). Cerulean [61] and Venus were amplified by PCR with
flanking NotI sites at both ends (primers 2182, 2183) and cloned in place of GFP
into the pcDNA3-Cterm vector.
GST-fusion constructs of rEAG1
Fragments of the cytosolic N-terminus of rEAG1 were obtained by PCR amplifica-
tion of the cDNA coding for the following segments: M1-T219 (N-term); M1-I209
(A); M1-G147 (B); M1-E96 (C); Q14-T219 (D); M70-T219 (E), K146-T219 (F). The
C-terminus (M478-S962) fragment was obtained by digestion of C-term-Cerulean
with BamHI and NotI restriction enzymes. The fragments were then subcloned
between BamHI and NotI restriction sites in the pGEX-4T-1 vector (GST-fusion,
Pharmacia). The primers used for the amplification of the rEAG1 fragments are
presented in Table 2.4.
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Forward primer Reverse primer
N-term-rEAG1 BamHINterm-fw NtermNotI-rv
Fragment A BamHINterm-fw Nterm-rv 627
Fragment B BamHINterm-fw Nterm-rv 441
Fragment C BamHINterm-fw Nterm-rv 288
Fragment D Nterm-fw 40 NtermNotI-rv
Fragment E Nterm-fw 208 NtermNotI-rv
Fragment F Nterm-fw 436 NtermNotI-rv
Table 2.4: Primers used for the amplification of rEAG1 fragments
YFP-CaM and YFP-apoCaM
The cDNA for rat Calmodulin II (CaM), a kind gift of Dr. M. Shea (Univ. of
Iowa, USA), was amplified by PCR with flanking NotI restriction sites (primers
2363, camnot rv) and subsequently cloned into the CB6-N-YFP vector to generate
N-terminus YFP-labeled Calmodulin (YFP-CaM). N-terminus YFP-labeled apo-
Calmodulin (YFP-apoCaM [50]) was a gift of Dr. D. Yue (Johns Hopkins Univ.,
USA). Mutations in all EF-hand domains render this version of CaM insensitive to
Ca2+.
(hSyn) Venus-CaM and Venus-apoCaM
In order to generate Venus-fusion [51] constructs of CaM and apoCaM for neuronal
expression, Venus was amplified by PCR with flanking NheI and NotI sites (primers
vencam-fw, 2183) and cloned into the pMH4-I-SYN vector. The cDNA cloning for
CaM and apoCaM, obtained by digesting the pcDNA3-based CaM constructs with
the NotI restriction enzyme, was subsequently cloned at the 3′ end of Venus to
obtain the pMH4-I-SYN-Venus-CaM and apoCaM vectors.
Introduction of point-mutations in the CaM-binding domains of
EAG1
Point mutations of the Calmodulin binding-sites of rat and human EAG1 were
generated using the PCR-based QuikChange mutagenesis kit (Stratagene), following
the instructions of the manufacturer.
Mutations F714S,F717S (described in [70]) were introduced into rEAG1 constructs
using primers fw cam mut r, rv cam mut r, and in their human counterparts using
primers fw cam mut h, rv cam mut h.
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The pairs of mutations F151S,A152S; V164S, L165S and V178S,H179D were intro-
duced in the N-terminus CaM-binding domains of hEAG1 and rEAG1 constructs
using the primers shown in Table 2.5.
Mutations Target Forward primer Reverse primer
F151S, A152S rEAG1 fw NtermMut2 rv NtermMut2
F151S, A152S hEAG1 fw NtermMut2 h rv NtermMut2 h
V164S, L165S rEAG1 fw NtermMut1 rv NtermMut1
V178S, H179D rEAG1 fw NtermMut3 rv NtermMut3
Table 2.5: Primers used in mutagenesis of N-terminus CaM-binding domains
2.2.2 Cell culture and transfection
HEK293 cells were cultured in DMEM:F12 (1:1) medium (Gibco), supplemented
with 10% FCS and 0.1% streptomycin/penicillin (Gibco) under 5% CO2 and hu-
midified conditions. Cells were plated on Poly-L-Lysine-coated glass coverslips and
transfected at 20-30% confluency using FuGene6 (Roche), according to the instruc-
tions of the manufactrer. The total amount of cDNA used was 0.5 µg per 15
mm cover slip. For co-transfections a cDNA ratio of 3:1 (m/m) was used (EAG
(donor):CaM (acceptor)).
Ca2+-ionophore treatment
For the CaM-binding FRET assay, cells were treated 36 hrs after transfection with
1 µM ionomycin (Calbiochem) in either Ringer solution with Ca2+ (“+Ca2+”) or
Ca2+-free Ringer with 1mM EGTA (“-Ca2+”), for 10 min at 37◦ C and subsequently
fixed for 25 min with 4% formaldehyde. After fixation cells were briefly washed in
PBS and mounted in Mowiol.
2.2.3 Microscopy
Cells were imaged on a Leica DMIRE2 inverted microscope equipped with a TCS
SP2 (AOBS) confocal scanner and a 63x NA1.4 HCX PL Apo objective (Leica).
The excitation laser lines and spectral collection window for each fluorophore are
detailed in Table 2.6. Spectral scans were acquired using 405 nm excitation-light and
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Table 2.6: List of fluorophores and respective spectral settings
Fluorophore Excitation max. Emission max. Laser line Collection range
(nm) (nm) (nm) (nm)
Cerulean [61] 433 470 405 / 458 470 - 505
GFP [82] 488 505 488 500 - 535
YFP / Venus [51] 515 528 514 525 - 610
Cy3 550 570 561 575 - 625
Cy5 649 670 633 652 - 730
a 4.5 nm spectral acquisition window, which corresponds to the minimal spectral
resolution of the Leica TCS SP2 (AOBS) scanner. The step-size for spectral scans
was equally set to 4.5 nm.
FRET measurements
Cerulean and YFP / Venus were excited using, respectively, the 458 and 514 nm
lines of an Argon laser. Cerulean emission was recorded in the 470-505 nm range and
YFP between 525-610 nm. This choice of Cerulean emission range produced images
with practically complete spectral separation from YFP emission. Photomultiplier
gain and offset values, as well as laser intensities were kept constant for all images
acquired of a given cell, before as well after bleaching of the acceptor fluorophore.
The pinhole opening was maximally opened during acquisition (5.2 Airy units).
Fluorescence Resonance Energy Transfer (FRET) was measured by the method of
Acceptor Photobleaching [4]. Images of both donor and acceptor constructs were
acquired before and after photo-destruction of YFP to 15% of its initial intensity,
in a region of interest inside a cell.
2.2.4 Image analysis and quantification
Image analysis was performed with Matlab (Mathworks) using custom-written
scripts that included components of the ImFluo toolbox (A.Esposito, E.N.I.,
Göttingen). In brief, donor images were binned (2× 2) and subsequently subjected
to low-pass Wiener and Gaussian filters with 3× 3 kernel dimensions. Background
signal was then removed by thresholding and FRET efficiencies calculated on a
pixel-to-pixel basis by determining the difference between donor intensities before
and after photobleaching of the acceptor and normalizing this value to the donor
intensity after photobleaching 1.4. Cumulative histograms of FRET efficiencies were
obtained by pooling FRET efficiency frequencies data for each experimental condi-
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tion (“+Ca2+”, “-Ca2+”, “apoCaM”, . . . ) and normalizing these frequencies to the
total amount of pixels accounted by each curve.
2.2.5 Overlay assays
GST-fusion proteins of the C- and N-termini of EAG were induced with 1 mM IPTG
in BL21 (DE3) E. Coli (Stratagene) and harvested after 4 hrs induction, lysed by
short sonication and boiled for 5 min in Laemmli’s loading buffer. Proteins were
separated by SDS-PAGE and either stained with Coomassie brilliant dye or trans-
ferred onto nitrocellulose membranes (Amersham). The membranes were blocked
overnight at 4◦ C with 5% (w/v) milk powder in TBS-T, followed by 2 hrs incuba-
tion at room temperature (RT) with 0.5 µg/ml biotinylated CaM (Calbiochem) and
1mM CaCl2 in TBS-T, washed once for 10 min in 0.5% Triton TX-100, 1 mM CaCl2
in TBS-T and twice for 10 min in 1 mM CaCl2 in TBS-T. Membranes were then
incubated for 1 hr with 0.2 µg/ml HRP-conjugated Streptavidin (Pierce) in TBS-T
with 1 mM CaCl2, washed four times for 5 min in the same buffer and detected
using the Enhanced Chemo-Luminescence kit (ECL, Amersham).
2.2.6 Generation of isoform specific antibodies against
rEAG1 and rEAG2
Selection of antigen peptides Rabbit polyclonal antibodies were generated
against short (15-22 aa.), isoform specific peptide sequences of rEAG1 and rEAG2.
The aminoacid sequences of both EAG isoforms were analyzed for potential epi-
topes. Both sequences were found to diverge mostly in their C-terminus cytosolic
domains, therefore, five peptide sequences were selected in this region, based on
potential antigenicity [34], solvent accessibility and degree of divergence from the
complementary EAG isoform. Moreover, the uniqueness of these sequences in the
rat proteome was verified using the BLAST program [1]. For rabbit immunization,
epitope peptides were coupled to immunogenic-carrier proteins through cysteines.
For this purpose, an extra cysteine was usually added to the N-terminus of each
peptide. Peptide synthesis, rabbit immunization, animal care and bleeding were
performed by BioGenes GmbH, Berlin.
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Epitope Peptide # Sequence Immunized Animals
rEAG1 aa. 794-808 49050 CLGPKAGGGDPAKRK #7194, #7195
rEAG1 aa. 930-944 49051 ILMSRGSSQSPQDTC #7196, #7197
rEAG2 aa. 836-849 49052 C-SMGLLSEDPKGSDS #7198, #7199
rEAG2 aa. 941-954 49053 C-LLSEKSVPQTSSPK #7200, #7201
rEAG2 aa. 720-733 49054 C-RNQGSAQSDPERSQ #7202, #7203
rEAG2 aa. 967-988 49055 CQDIFSVSRPESPESDKDEINF #7204, #7205
Table 2.7: Antigen peptides used for polyclonal antibody production. “C-” denotes a
cysteine introduced for coupling purposes.
Testing The antisera of immunized rabbits was tested for immunofluorescence
applications on HEK293 cells transfected with rEAG1-GFP or rEAG2-GFP and
fixed with 4% formaldehyde. Cells were stained (see §2.2.8) with serum dilutions
of 1:5000, 1:1000, 1:500 and 1:100. Antiserum #7194 was able to recognize cells
transfected with rEAG1-GFP with a low background at a 1:5000 dilution. Similarly,
antiserum #7205 was able to recognize rEAG2-GFP transfected cells with a very low
background when used in a 1:5000 dilution. These two antisera were isoform specific,
as they did not recognize cells transfected with another EAG isoform. Moreover,
no immunofluorescent signal was observed when the pre-immunization sera of both
animals were used, further confirming the ocurrance of an immune-response against
the injected peptides.
Affinity purification Antisera #7194 and #7205 were purified by affinity chro-
matography using the SulfoLink kit (Pierce) according to the manufacturers instruc-
tions. In brief, 1.3-1.6 mg of antigen peptides 49050 and 49055, used for immuniza-
tion of animals #7194 and #7205, respectively, were coupled to SulfoLink columns
via sulfhydril groups. The antigen-bound columns were incubated with their respec-
tive antisera and washed. Purified antibodies were then eluted using a low pH (2.5
- 3.0) buffer, dialyzed and stored at -20◦ C in a buffer containing 100 mM TRIS pH
7.4, 150 mM NaCl, 1 mg/ml BSA and 0.025% NaN3.
2.2.7 Primary culture of hippocampal neurons
Neuronal cultures were prepared from the hippocampi of embryonic day 18 Wistar
rats as described elsewhere [3], with a few modifications. Hippocampi were isolated,
digested for 15 min at 37◦ in a Trypsin solution and dispersed mechanically. Fol-
lowing a short centrifugation, cells were resuspended in Neurobasal neuronal culture
medium (without Phenol Red) supplemented with B27, 0.5 mM L-Glutamine and
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5 ng/ml FGF (all from Invitrogen), counted, and plated at an appropriate density
on glass coverslips coated with poly-L-Lysine (Sigma) and Laminin (Sigma).
Transfection of primary hippocampal neurons
Primary neuronal cultures were transfected on the third day after plating (3 DIV)
using the Lipofectamine2000 (Invitrogen) transfection reagent and according to the
instructions of the manufacturer. A total amount of 2 µg cDNA and 3 µl Lipofec-
tamine per 25 mm coverslip was used. For co-transfections cDNA ratios of 3:1 to
10:1 (m/m) were used (EAG (donor):CaM (acceptor)).
2.2.8 Immunofluorescence
For immunostainings, cells were briefly washed with ice-cold PBS and fixed for 30
min with 4% formaldehyde (FA) at RT. Residual FA was quenched with 100 mM
Glycine in PBS for 5 min, and cells were permeabilised for 5 min with 0.1% Triton
X-100 in PBS and blocked with 0.2% Gelatine in PBS for 10 min. Subsequently,
cells were incubated with the primary antibodies at appropriate dilution (see Table
2.3) for 45 min at RT, washed four times for 5 min with incubation buffer and in-
cubated with fluorophore-conjugated secondary antibodies. Next, cells were washed
four times for 5 min with incubation buffer, once with PBS for 10 min and once,
briefly, with destilled water before mounting in ProLongGold antifade reagent (In-
vitrogen).
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Results
3.1 Photoconversion product of YFP interferes
with acceptor photobleaching measurement
of FRET between Cyan and Yellow Fluores-
cent Proteins
The Cerulean/YFP FRET pair [46,61] was used in an intermolecular FRET assay for
the binding of CaM to EAG1. FRET was measured by acceptor photobleaching in
HEK293 cells co-transfected with Cerulean-fused hEAG1 and YFP-CaM. Cerulean
was excited using 405 nm or 458 nm laser light, whereas YFP was imaged and
bleached using the 514 nm line of an Ar laser. The differences in donor intensity
before and after photo-destruction of the acceptor fluorophore in a region of interest
were calculated on a pixel to pixel basis and normalized to the post-bleach donor
intensity in order to determine FRET efficiency values. FRET efficiencies for each
pixel are displayed in a color-coded image and plotted in a frequency histogram (Fig.
3.2).
FRET efficiencies measured using 405 nm excitation were consistently high in the
nucleus of cells expressing high levels of YFP-CaM (Fig. 3.2 B) However, hEAG1 was
not expressed in the nucleus and areas with low intensities of the donor also revealed
high FRET efficiencies. Furthermore, cellular regions which were not bleached,
showed no significant changes in donor intensity, thereby excluding any artifacts
due to movement of the sample or laser power instability.
In order to test if the increase in the donor intensity was due to genuine FRET,
occurring in an area with a low population of donor molecules, or to an artifact of
Cerulean or YFP, the acceptor photobleaching protocol was repeated in cells trans-
fected with hEAG1-Cerulean or YFP-CaM on their own (data not shown).
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Figure 3.2: Photoconversion of YFP in HEK cells co-transfected with
hEAG1-Cerulean and YFP-CaM. (A) Fluorescence emission in 465-505
nm range (CFP/Cerulean) with 405 nm excitation and in the 525-610 nm
range (YFP) with 514 nm excitation, before and after photobleaching
of YFP in a portion of the cell (white box) by continuous scanning with
the 514 nm laser line. (B) FRET efficiency map. (C) Corresponding
normalized cumulative histogram of FRET efficiencies.
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Figure 3.3: Excitation of the photoconversion product of YFP is more effective at 405
nm than at 458 nm. Sepharose beads covalently coupled to purified YFP. Upper row: Flu-
orescence emission in 465-505 nm range (CFP/Cerulean) with 405 and 458 nm excitation
and in the 525-610 nm range (YFP) with 514 nm excitation. Middle row: Emission of
CFP and YFP channels after photobleaching of YFP in a specific portion of the bead by
continuous scanning with the 514 laser line. Lower row: Colour-coded difference image
(∆Fdonor = DonorPost - DonorPre) showing increase in fluorescence intensity in the 465-505
nm spectral range.
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Cells expressing only hEAG1-Cerulean showed no increase in intensity upon irradi-
ation with 514 nm light whereas cells expressing YFP-CaM showed a large increase
in intensity in the donor channel (465-505 nm) after photobleaching of YFP and
upon excitation with 405 nm. A smaller, but nevertheless significant increase was
seen when 458 nm excitation was used . This intensity increase was limited to areas
where YFP was bleached with 514 nm light. As no donor is present, this indicates
that YFP could be photochemically converted to another fluorescent species (hence-
forth denoted XFP). In order to further characterize this photochemical reaction the
bleaching procedure was performed in transfected live cells, fixed cells embedded in
anti-oxidant medium (ProLongGold, Invitrogen) and in cells transfected with YFP
on its own or Venus-CaM [51]. In all cases the bleaching of the yellow fluorophore re-
sulted in the formation of XFP, which had significant emission in the spectral region
of CFP/Cerulean (465-505 nm) when 405 or 458 nm excitation was used.
In order to exclude that cellular components are catalysing the photoconversion,
YFP-coupled sepharose microbeads (a gift of Dr. F. Wouters) were mounted in
Mowiol and partially bleached using the 514 nm laser line. Again, the bleaching of
YFP led to a substantial increase in the fluorescence in the 465-505 nm range upon
405 nm excitation, and to a smaller increase when 458 nm excitation was used (Fig.
3.3). A spectral scan of the bleached regions in the range 415-640 nm, acquired
using 405 nm excitation (Fig. 3.4) revealed an emission peak at ∼ 470 nm for the
XFP photoconversion product, i.e. overlapping with the CFP/Cerulean emission
peak at 476 nm.
The effect of the XFP photoconversion product on FRET efficiencies measured by
acceptor photobleaching depends mostly on the relative concentrations of donor and
acceptor. It is therefore of special importance for intermolecular biosensors in which
donor and acceptor flurophores are fused to different constructs. Higher concentra-
tions of YFP will result in the formation of larger amounts of XFP whose impact
on FRET efficiencies will depend on the relative intensity of CFP/Cerulean donor
molecules. This is due to the fact that increases in donor fluorescence (∆Fdonor) are
normalized to the total donor intensity in each pixel in order to calculate FRET effi-
ciencies (see Eq. 1.4). In areas such as the nucleus of cells transfected with hEAG1
even small intensity changes due to the photoconversion of YFP will result in large
apparent FRET efficiencies. The use of 458 nm excitation instead of 405 nm can
therefore reduce the effect of YFP photoconversion on FRET efficiencies, since it is
much less efficient at exciting XFP than 405 nm.
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Figure 3.4: Spectral scan (415 - 640 nm) of the emission of the YFP photoconversion
product. Sepharose bead covalently coupled to purified YFP. Middle square was bleached
by continuous scanning at 514 nm. (A) XFP emission under 405 nm excitation, one image
was taken for every 4.5 nm portion of the spectrum. (B) Plot of fluorescence intensities
for bleached (green) and unbleached (blue) regions of bead.
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For the experiments described in this work, Cerulean was imaged using 458 nm ex-
citation light and regions of low donor expression, such as the nucleus, were thresh-
olded. No effects of YFP photoconversion were detected after these two measures
were applied. This was verified by using a biological control: acceptor photobleach-
ing measurements of FRET between hEAG1-Cerulean and YFP-apoCaM - a mu-
tated form of CaM which does not bind Ca2+ and, therefore, does not interact with
the CaM binding domain of EAG1 (Fig. 3.5 F). No FRET was measured between
both constructs, confirming the absence of photoconversion artifacts.
3.2 FRET assay for the Ca2+-dependent interac-
tion of EAG with CaM
Expression of fluorescent-fusion constructs of EAG1 and CaM in HEK
cells
In order to establish a FRET assay for the Ca2+/CaM-mediated regulation of EAG1
channels, channel subunits were labeled with fluorescent proteins at the C-terminus
and CaM at the N-terminus.
When hEAG1 was fused at the C-terminus with EGFP and expressed in different
mammalian cell lines, its fluorescence signal was located mostly in small vesicles in
the cytoplasm and in the endoplasmatic reticulum (ER) / nuclear envelope (data not
shown). Occasionally a membrane staining was discernible as a faint contour line.
This expression pattern was the same as that of non-labeled overexpressed (pTracer-
heag1) channels (G. Bunt, personal communication) as detected by a monoclonal
antibody (anti-33) recognizing an epitope in the intracellular part of the channel.
The currents and kinetics of GFP-fused hEAG1 were furthermore indistinguishable
from those of non-labeled channels (F. Monje, data not shown). This indicates that
C-terminal fusion of the channel subunits to fluorescent proteins does not largely
interfere with the localization and functionality of the channel.
For FRET experiments, the EGFP fused to EAG1 was exchanged by either the
donor or acceptor of the EGFP-derived FRET pair Cerulean-YFP. Optimization
experiments with the cytosolic C-terminus of rEAG1 showed that FRET could only
be measured when EAG1 was labeled with the donor fluorophore Cerulean and CaM
with the acceptor YFP, and not vice-versa. This configuration was therefore used
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throughout this work.
In order to characterize the interaction of EAG1 with CaM by FRET, the Cerulean-
fused cytosolic C-terminus of rEAG1 was initially co-expressed with YFP-CaM in
HEK cells. The C-terminus of the channel was localized uniformly across the cy-
toplasm but absent from the nucleus, whereas CaM was present in both of these
cellular compartments. Therefore, regions of interest for FRET measurements were
selected in the cytoplasm. Furthermore, in this study Cerulean was excited using
the 458 nm laser line to avoid photoconversion effects of YFP.
Figure 3.5: FRET measurements between EAG1-Cerulean (donor) and YFP-labeled
CaM (acceptor), by acceptor photobleaching. HEK cells were co-transfected with either
the cytosolic C-terminus of rEAG1 (A - C) or the full-length hEAG1 (D-F) labeled with
Cerulean and YFP-labeled CaM constructs (A and D) and treated with 1µM ionomycin
in the presence of 1.8 mM Ca2+; or (B and E) with 1µM ionomycin in the presence
of 1mM EGTA for 10 min. (C-F) Co-transfection with apoCaM and stimulation with
ionomycin in the presence of 1.8 mM Ca2+. Bleached areas are indicated by white boxes;
Measured FRET is presented as efficiency map (colorscale maximum = 0.30). Correspond-
ing normalized cumulative histogram of FRET efficiencies of several cells (n=11).
To investigate the Ca2+-dependency of the EAG1-CaM interaction, cells were placed
in Ringer with either a high Ca2+ (1.8 mM Ca2+) or a low Ca2+ concentration (no
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Ca2+, 1 mM EGTA) and stimulated with 1µM ionomycin, in order to artificially
induce extreme intracellular Ca2+ conditions. Subsequently, cells were fixed and
FRET was measured (Fig. 3.5).
No significant differences in the localization of the constructs was seen upon Ca2+
depletion or increase. However, in FRET experiments, the C-terminus of the channel
was found to interact with CaM in a Ca2+-dependent manner. (Fig. 3.5 A,B,G).
Cells with increased Ca2+ concentrations showed FRET efficiencies ranging up to
35%, with an average of 9.8%, whereas in cells with depleted Ca2+ no FRET could
be measured. In the cumulative histogram of the pooled FRET efficiencies of several
cells, this is seen as a shift of the FRET distribution curve to the left upon Ca2+
depletion, peaking around zero. This indicates that Cterm-rEAG1 binds CaM in
its Ca2+-bound state only (Fig. 3.5 G). This is verified by the expression of the
Ca2+-insensitive construct, YFP-apoCaM, as acceptor. The FRET distributions of
apoCaM-transfected cells overlap those of Ca2+-depleted cells.
This Ca2+-dependent interaction with CaM was also found for the full-length hEAG1
channel. It displayed high FRET efficiencies with YFP-CaM, with an average of
17% and values ranging up to 40%, in the presence of Ca2+ (Fig. 3.5 D, H). In
Ca2+-depleted cells, a reduced FRET-efficiency distribution with an average at 10%
was obtained (Fig. 3.5 E, H). However, in cells where hEAG1-Cerulean was co-
transfected with YFP-apoCaM, even in the presence of Ca2+, no FRET could be
measured (Fig. 3.5 F, H). This indicates that the full-length channel is not capable of
binding CaM in its Ca2+-unbound state. Consequently, it can be assumed that, even
after depletion of Ca2+ in the presence of EGTA, there still are Ca2+-bound CaM
molecules that account for the measured FRET efficiency. Moreover, the fact that
no FRET was measured for the C-terminus under low Ca2+ conditions suggests that
the full-length protein has a higher affinity for Ca2+ than the C-terminus alone.
Mutation of the CaM binding domain (F714S, F717S) of EAG1 prevents
binding of CaM to the C-terminus but not to the full-length hEAG1
channel
To understand the difference in Ca2+-dependent behaviour between the C-terminus
and the full-length channel, EAG1 constructs carrying the mutations F714S, F717S
in the C-terminal CaM-binding domain (CaMbd) were made (CtermF114S,F117S-
Cerulean and hEAG1F114S,F117S-Cerulean). These mutations were previously found
[70] to inhibit the binding of CaM to the C-terminus of hEAG1, resulting in Ca2+-
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insensitive currents. The expression pattern of both mutation-containing constructs
was not changed in comparison to their their wild-type counterparts. These con-
structs were co-expressed with YFP-CaM and subsequently exposed to extreme Ca2+
conditions prior to fixation.
The mutations F714S, F717S indeed inhibited the interaction of CaM with the C-
terminus of rEAG1, since no FRET was measured under both the high and low
Ca2+ conditions, as well as with apoCaM (Fig. 3.6 A-F).
Figure 3.6: FRET measurements between EAG1-Cerulean with mutated CaMbd (F714S,
F717S) and YFP-labeled CaM. HEK cells were co-transfected with the CaMbd-mutated
cytosolic C-terminus of rEAG1 (A - C) or full-length hEAG1 (D-F) labeled with Cerulean
and YFP-labeled CaM constructs. Cells were treated with 1µM ionomycin in the presence
of 1.8 mM Ca2+ (A, D); (B, E) or treated with 1µM ionomycin in the presence of
1mM EGTA. (C-F) Co-transfection of the EAG1 constructs with apoCaM and treatment
(“+Ca2+”) with 1µM ionomycin for 10 min. in the presence of 1.8 mM Ca2+; (G, H)-
normalized cumulative histogram of FRET efficiencies of several cells (n=11).
However, the results obtained with the full-length channel containing these CaMbd
mutations show an interaction with YFP-CaM (with FRET efficiencies averag-
ing around 10 % and ranging up to ∼25%) under both high Ca2+ conditions,
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as upon Ca2+ depletion. No significant differences in the FRET efficiencies of
“+Ca2+” / “-Ca2+” cells were found. Furthermore no FRET was recorded between
hEAG1F114S,F117S-Cerulean and YFP-apoCaM, again verifying that no interaction
occurs with Ca2+-unbound CaM.
These results show that the previously reported [70] mutations in the C-terminal
CaM binding site (F114S, F117S) of EAG1 indeed prevent the binding of CaM
to the truncated, cytosolic C-terminus of the channel but not to the full-length
protein. This implies that the full-length channel has either a higher affinity for
CaM or can bind more CaM molecules than the C-terminus. Thereupon, it could
be argued that the absence of measurable FRET for the mutated C-terminus is
simply a consequence of a lowered affinity of the CaMbd. Mutations in the full-
length channel also lower the affinity, however not down to zero as the initial CaM
affinity is higher for this construct, as a result of a more stable conformation of the
full-length protein. However, the fact that the full-length construct does not display
Ca2+-dependent changes in FRET efficiency favours the hypothesis of the existance
of a second active binding site with a lower dissociation constant (Kd), i.e. a higher
Ca2+/CaM affinity, in the full-length channel. This putative site may be located in
the cytosolic C-terminal tail - in which case it requires other parts of the channel
subunit in order to be functional - or at another upstream location.
Figure 3.7: FRET measurements between the EAG1 and CaM. Normalized cumulative
histograms comparing the obtained FRET efficiencies for CaMbd-mutated and wild-type
C-terminus (A) and full-length EAG1 (B) constructs (n=11).
3.2.1 CaM binds directly to the N-terminus of EAG1
In order to screen for other potential CaM binding sites, in addition to the domain
previously described in the C-terminus (aa. 707-726), the sequences of the intracel-
lular tails of the channel were analyzed with a computational algorithm for CaM
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binding sites [94]. This suggested the existence of a binding site in the N-terminus
at aa. 145-162 and two binding sites in the cytosolic C-terminus domain of hEAG1:
the aa. 707-726 previously proposed by Schönherr et al. [70] and a second site at aa.
668-679 with an even higher CaM affinity.
Initially, the N-terminus of EAG1 was screened biochemically for the presence of
CaM binding domains. The N-terminus cytosolic tail is, with 219 aa. , the second
largest cytosolic segment of the channel subunit, after the C-terminus.
The cDNA coding for the cytosolic N-terminus domain of rEAG1 (aa. 1-219), as
well a six shorter fragments (A-F see Fig. 3.8 A) were fused to GST in a bacterial
expression vector and the proteins were expressed in BL21 (DE3) E. Coli. The
bacterial lysates were separated on a 10% SDS-Polyacrylamide gel (3.8 B) revealing
the prominent bands of the expressed constructs. The GST-fused C-terminus and
GST on its own were included as positive and negative controls, respectively.
Figure 3.8: Calmodulin binds to segment aa. 147-209 of the N-terminus of rEAG1.
Fragments of the N-terminus of rEAG1 were fused to GST (A) and bacterially expressed.
(B) Coomassie-stained acrylamide gel loaded with bacterial lysates expressing fragments
of the N-terminus and corresponding overlay blot (lower panel) incubated with biotinylated
CaM in the presence of 1 mM Ca2+. Detection with HRP-conjugated streptavidin yielded
prominent bands for every fragment except B and C, these segments do not contain aa.
147-209. (C) Amino acid sequence of the segment aa. 147-209 of rEAG1. The two putative
1-8-14 CaM binding motifs are highlighted.
The bacterial whole cell lysates were transferred onto a nitrocellulose membrane
and incubated with biotinylated CaM. The resulting overlay blot showed binding of
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CaM to the N-terminal fragments with the exception of B and C. The GST-fused
C-terminus, included as a positive control, also displayed a strong band, indicating
a strong interaction with CaM. The fragments B and C do not contain the segment
aa. 147-209, implying that a CaM binding domain may be present in this sequence.
This is in accordance to the results of the computational screening.
Upon closer inspection of this sequence, two adjacent, putative Ca2+-dependent
CaM-binding motifs of the 1-8-14 type were found at aa. 151-164 and 165-178 (3.8
C). Both sequences are located on a stretch which is predicted to be amphipathic and
composed mostly of basic and hydrophobic residues. The second putative binding
motif contains a proline, an aminoacid that seldom appears in amphipathic helices,
which does not imply that this site cannot be involved in CaM binding.
Mutations F151S, A152S prevent the binding of CaM to the N-terminus
of the EAG1
Mutations were introduced in the 1-8-14 motifs of the N-terminus of rEAG1 in order
to localize the residues needed for the interaction with CaM. CaM binding sites of
the 1-8-14 type are particularly sensitive to mutations in the first (Pos. 1) and last
(Pos. 14) hydrophobic residues [60]. Three pairs of mutations were inserted in the
GST fusion construct of the N-terminus.
The mutations L151S and A152S, were aimed at disrupting the hydrophobic region
at the beginning of the first 1-8-14 motif at aa. 151-165. They should, in principle,
affect this motif only and therefore provide information on whether both or only the
first of the putative motifs actively binds CaM.
The middle mutations, V164S and L165S, were introduced with the intent of dis-
rupting both adjacent 1-8-14 motifs in one construct. This was done by mutating
the last hydrophobic amino-acid (V) of the first motif (aa. 151-164) and the first
amino-acid (L) of the second motif (aa. 165-178). The hydrophobic amino-acids
were replaced by serines, a residue of hydrophilic nature whose charge and size
should minimise long range consequences of the substitutions. As a result of these
mutations a 9 aa. long hydrophilic segment is created (aa. 159-168), which should
hinder the formation of an amphipathic helix, a characteristic of functional 1-8-14
CaM-binding domains [60].
The third pair of mutations - V178S, H179D - target the last hydrophobic residue
of the second putative 1-8-14 binding site (aa. 165-178), as well as an adjacent basic
RESULTS 35
residue that was replaced by an acidic amino-acid.
The 3 constructs thus obtained were expressed in bacteria and tested biochemically
for CaM binding on an overlay blot.
Figure 3.9: Mutations F151S, A152S disrupt the binding of CaM to the N-terminus of
rEAG1. Overlay blot of the N-terminus of rEAG1 containing mutations in the region aa.
151-179. Detection with HRP-conjugated streptavidin revealed that mutations V164S,
L165S and V178S,H179D caused a reduction in the binding of biotinylated CaM, whereas
mutations F151S, A152S completely disrupted binding.
The overlay blot comparing the CaM binding of the wild-type GST-N-Term and the
three mutants is shown in Fig. 3.9. Mutants V164S, L165S and V178S, H179D,
involving the second 1-8-14 motif, display reduced binding to biotinylated CaM,
in comparison to the wild-type GST-N-Term. However, only the mutation pair
F151S, A152S, at the beginning of the first 1-8-14 motif, led to the disruption of
binding.
These results show that the first 1-8-14 binding motif is the dominant CaM-binding
domain in the N-terminus cytosolic segment of EAG1.
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3.2.2 hEAG1 channels with mutated N-terminal (F151S,
A152S) and C-terminal (F714S, F717S) CaMbd are
unable to bind CaM
The effect of the N-terminus CaMbd in the full-length channel was investigated by
FRET microscopy. The mutations F151S, A152S were introduced in both wild-type
hEAG1 and in a mutant with a disrupted C-terminal CaM-binding domain. FRET
was measured by acceptor photobleaching in HEK293 cells under low and high Ca2+
conditions (Fig. 3.10).
Figure 3.10: Mutations of the CaM binding domains in N- and C-termini completely
disrupt the binding of CaM to hEAG1. Measurement of FRET by acceptor photobleach-
ing in cells co-transfected with YFP-CaM and (A) hEAG1F151S,A152S,F714S,F717S or (B)
hEAG1F151S,A152S after treatment with 1µM ionomycin in the presence of 1.8 mM Ca2+.
(C) Mutations in the N-terminus CaM binding domain reduce but do not completely
disrupt the binding of CaM to the channel - cf. Fig. 3.7 (n=10).
Constructs of hEAG1 containing both the mutated N- and C-terminal CaM binding
domains were found not to interact with YFP-CaM, as no FRET could be measured.
Fusion constructs of hEAG1 containing only the N-terminal mutations F151S and
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A152S interacted with YFP-CaM (revealing FRET average efficiencies of ∼10% and
ranging up to 30%).
The combined four mutations F151S, A152S, F714S, F717S are therefore sufficient to
hinder the binding of CaM to hEAG1. This implies that these two binding sites are
responsible for CaM binding, although other binding sites can still be involved in the
binding mechanism in a cooperative manner (e.g., the putative binding site found
in silico). Even though no FRET interactions were detected between the truncated
C-terminus with a mutated CaM binding domain (F114S, F117S) and YFP-CaM,
there remains the possibility that a putative site at aa. 668-679 is functional but
requires a full-length channel in order to bind CaM.
In conclusion the present results show that two CaM binding sites are present in
hEAG1 subunits - a high-afinity CaM binding domain of the form 1-8-14 in the
N-terminus and the previously described C-terminal binding domain at aa. 707-
276. Mutations at these sites lead to the complete disruption of CaM binding to
the hEAG1, these two binding domains are therefore responsible for CaM binding.
These findings indicate that the regulation of hEAG1 by Ca2+/CaM is more complex
than previously thought.
3.2.3 The EAG2 homologue interacts with CaM in a Ca2+-
dependent manner
Although EAG1 and its homologue EAG2 share a significant part of their amino-
acid sequence (Fig. 3.11 E), the binding of EAG2 to CaM has so far not been
described. In order to verify if EAG2 is interacting with CaM, FRET measurements
were performed in cells co-transfected with a Cerulean-fusion construct of rEAG2
and YFP-CaM/EYFP-apoCaM (Fig. 3.11). Cerulean-labeled rEAG2 was located
mostly in the endoplasmatic reticulum and Golgi network, with a few vesicles being
visible in the cytosol. This localization was characteristic of the fluorescent fusion
constructs of rat variants of EAG1 and EAG2, which displayed a higher tendency
to remain in the secretory apparatus of cells.
rEAG2 was found to interact to interact with CaM in a Ca2+-dependent manner
similar to hEAG1. The FRET efficiencies distribution peaked for high Ca2+ condi-
tions with an average of 14%. This indicates that a the mechanism of Ca2+/CaM
binding is probably conserved in EAG isoforms, and not limited to EAG1.
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Figure 3.11: FRET measurements between rEAG2-Cerulean and YFP-labeled CaM.
HEK cells were co-transfected with rEAG1 (A-C) labeled with Cerulean and YFP-labeled
CaM constructs. Cells were treated with 1µM ionomycin in the presence of 1.8 mM
Ca2+ (A); or (B) treated with 1µM ionomycin in the presence of 1mM EGTA. (C) Co-
transfection of rEAG2 with apoCaM and treatment (+Ca2+) with 1µM ionomycin for 10
min in the presence of 1.8 mM Ca2+; (D)- Normalized cumulative histogram of FRET
efficiencies of several cells (n=10). (E) Sequence alignment of the N and C-terminal CaM
binding domains of hEAG1, rEAG1 and rEAG2. The position of the CaMbd-disrupting
serine substitutions (S*) is conserved
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3.3 Study of the localization and Ca2+/CaM regu-
lation of EAG in rat hippocampal cultures
EAG1 channels have been shown to affect neuronal excitability in Drosophila
melanogaster, as eag mutants reveal a high rate of spontaneous activity [8, 21, 31].
This phenotype is compatible with the channel’s activation threshold being close
to the membrane resting potential. Therefore, the regulation of the channel by
Ca2+/CaM can have a strong effect on neuronal activity. However, the physiological
role of EAG1 as well as its regulation in neurons is not yet well understood. In order
to gain insight in the spatio-temporal resolution of the EAG1/CaM interaction in
the regulation of neuronal excitability, studies of the localization of EAG in neu-
rons were performed and a FRET assay for CaM binding implemented in primary
hippocampal cultures.
Expression of rEAG1-Cerulean in rat hippocampal neuronal cul-
tures
rEAG1-Cerulean and YFP-CaM were cloned under the control of the human
Synapsin promoter, and transfected in E18 dissociated hippocampal cultures. The
synapsin-promotor restricts the expression of the channel to neurons [32]. This was
verified by co-staining of the transfected cells with neuron-specific anti-βtubulin III
antibodies [17,76].
When transfected in neuronal cultures and at 12 days-in-vitro (DIV) rEAG1-
Cerulean had an expression pattern consisting mostly of small vesicular structures
in the cytosol, which were present in soma, dendrites and axons. The latter was
shown by co-staining with dendrite-specific MAP2 antibodies [12,41], where rEAG1
was expressed in both MAP2-positive as well as negative neurites (Fig. 3.16). Addi-
tionally, rEAG1 transfected neurons showed no significant morphological differences
when compared to untransfected cells. In order to verify if bursts of neuronal ac-
tivity have an immediate effect on rEAG1 distribution, transfected cultures were
stimulated with 90 mM K+ for 180 s. No differences in expression pattern resulted
from this stimulation.
Endogenous EAG1 channels have been shown to be present at both RNA [18,39,66]
and protein level [25] in the hippocampus of adult rats, predominantly in the regions
CA2, CA3, CA4, and DG, but also in CA1. However, the subcellular localization of
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EAG1 in these regions is not known.
Subcellular localization of EAG channels in rat hippocampal neuronal
cultures
In order to investigate the intracellular localization of EAG channels 12 polyclonal
antibodies were raised in rabbits against 6 isform-specific epitopes in the intracel-
lular parts of the C-terminus of rEAG1 (2) and rEAG2 (4). The sequence of the
C-terminus of the channel has several zones of high potential antigenicity and, more-
over, contains less similarities between EAG1 and EAG2.
These antibodies were screened for use in immuno-fluorescence in formaldehyde-
fixated HEK cells transfected with rEAG1-GFP or rEAG2-GFP fusion constructs.
The anti-rEAG1 #7194 (against aa. 794-808) and anti-rEAG2 #7205 (aa. 967-988)
antibodies were selected for their ability to recognize their targets with a low back-
ground while remaining specific for an EAG isoform (Fig. 3.12). The optimal final
concentration was ∼3 µg/ml for both antibodies.
Hippocampal cultures of E18 rats at culture stages between 7 and 23 DIV were
fixed with 4% formaldehyde and stained with anti-rEAG1 7194 and anti-rEAG2
7205 antibodies . Cultures stained with anti-rEAG1 antibodies at different concen-
trations displayed no detectable signal. However, the same antibody was capable of
detecting overxpressed rEAG1-GFP, again with no signal being detected in adjacent
untransfected cells (Fig. 3.13). This implies that the amounts of endogenous rEAG1
in hippocampus primary cultures with 7-23 DIV are indeed very low in comparison
with the overexpressed channel. In contrast, in cultures stained with anti-rEAG2
antibodies a few cells with a punctated fluorescent signal were present along neu-
ronal processes (both MAP2 positive and negative) and also in cells which were not
co-stained with MAP2 at all (Fig. 3.14). Since MAP2 is a marker of the somato-
dendritic compartment of neurons [12,41], these results may indicate that EAG2 is
also present in non-neuronal cells of hippocampal primary cultures.
Endogenous rEAG2 also partially co-localized with p38, although, given the high
density of the p38 staining some co-localization is always to be expected (Fig.
3.15).
There is no extensive literature on the subcellular localization of EAG channels. One
article [25] describes the distribution of rEAG1 and rEAG2 in dissociated E18/E19
rat hippocampal cultures. In that study EAG1 was found to be expressed in the
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Figure 3.12: Tests for the use of anti-rEAG antibodies in immunofluorescence. HEK293
cells expressing GFP-fusion constructs of rEAG1 and rEAG2 (green) were fixed with
4% formaldehyde and stained with #7194 anti-rEAG1 and #7205 anti-rEAG2 antibodies
(red). Both antibodies were able to recognize their antigens specifically, with no cross-
reactivity for the other rEAG isoform (lower rows). The optimal final concentration for
both antibodies was ∼3 µg/ml.
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Figure 3.13: Immunostaining of rEAG2 in rat hippocampal cultures (E18, 12 DIV)
transfected with (hSyn) rEAG1-GFP. Overexpressed rEAG1 (green) is detected by #7194
antibody (red) whereas no endogenous signal is found in surrounding cells, which were
stained with p38 antibody (blue).
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Figure 3.14: Immunostaining of rEAG2 in rat hippocampal cul-
tures (E18, 20 DIV). (A) Endogenous rEAG2 (green) puncta are
detected with #7205 antibody in neurites stained with MAP2
(red) but also in MAP2 negative processes. (B) Endogenous
rEAG2 puncta are also present in cell bodies that were not stained
with MAP2 (arrowhead).
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Figure 3.15: Rat hippocampal cultures (E18, 20 DIV) double stained for rEAG2 (#7205
antibody, green) and p38 (red). Many p38 puncta do not colocalize with rEAG2, whereas
most rEAG2 puncta do colocalize with p38.
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somatodendritic compartments of hippocampal neurons, in particular in the excita-
tory post-synaptic terminals since it co-localized with MAP2 positive processes as
well as with p38 and Densin clusters (markers of chemical synapses and glutamater-
gic synapses, respectively). However, unpublished electron microscopy studies have
found EAG1 to be present in the pre-synaptic terminals of rat hippocampal neurons
(M. E. Rubio and L. Pardo, personal communication).
A co-staining of overexpressed rEAG1-GFP with p38 antibodies revealed little co-
localization of EAG1 and p38 clusters. Both stainings are very dense making it very
likely that some degree of co-localization occurs.
Figure 3.16: Rat hippocampal cultures (E18, 14 DIV) transfected with (hSyn)rEAG1-
GFP (green). Co-staining with MAP2 (red, upper rows) reveals that overexpressed rEAG1
is present in the somato-dendritic compartment (upper row) but also in axons (middle
row). Co-staining with p38 (lower row) shows little colocalization between both proteins.
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Expression of Venus-CaM and Venus-apoCaM in dissociated embryonic
rat hippocampal cultures
Endogenous CaM is expressed ubiquitously and abundantly in neuronal tissue, pre-
dominantly in neurons, but is also present in glia [11,14,91]. In neuronal cells CaM
is expressed foremostly in the soma and dendrites [11]. Axons and pre-synapses
have CaM in smaller amounts [11].
Venus-CaM and Venus-apoCaM constructs under the control of the human Synapsin
promoter were transfected into E18 embryonic hippocampus cultures which were
fixed and imaged at 10-12 DIV. Both fusion proteins were expressed cytosolically
throughout the cells. Fluorescently-labeled CaM was present only in small amounts
in the nucleus, whereas the concentration of apoCaM was similar in both nucleus
and cytoplasm.
There were morphological differences between cells expressing Venus-CaM and
those expressing Venus-apoCaM. In general, cells expressing Venus-CaM had more
outgrowths and more neurite branching than both apoCaM-expressing and non-
transfected cells.
CaM has been described to translocate from the cytoplasm of neurons to the nucleus
upon sustained depolarization (90 mM K+ for 180 s.) [16]. This was verified for the
cultures used in this work (Fig. 3.18).
Upon K+ stimulation neither Venus-CaM- nor Venus-apoCaM- transfected cells dis-
played differences in the nuclear CaM concentration (Figs. 3.17). However, cells
transfected with Venus-CaM did have an increase in the number and size of spiny
outgrowths. Although the translocation of CaM to the nucleus has been shown to
occur upon Ca2+ binding [16,44], Venus-apoCaM was present in higher amounts the
nucleus than its Ca2+-binding counterpart.
3.3.1 FRET measurements in neurons co-transfected with
rEAG1-Cerulean and Venus-CaM
Dissociated hippocampal cultures of E18 rats were co-transfected with (hSyn)Venus-
CaM and (hSyn)rEAG1-Cerulean. Similarly to HEK293 cells, co-transfected neu-
rons tend to display robust Venus-CaM fluorescence and only a faint rEAG1-
Cerulean signal. When cDNA transfection ratios of 3:1 (rEAG1/CaM, m/m) were
RESULTS 47
Figure 3.17: Overexpression of Venus-fused CaM and apoCaM (green) in rat hip-
pocampal cultures (E18, 10-12 DIV). Co-staining with anti-MAP2 antibody (red). Both
fluorescent-fusion proteins are expressed throughout the cytosol of neurons and only
apoCaM is present in large amount in the nucleus. Neurons transfected with Venus-CaM
show increased neuritogenesis and branching of processes. No translocation of CaM con-
structs occurred upon stimulation with 90 mM K+ for 180 s, however neurons transfected
with Venus-CaM displayed increased fluorescence in filopodia/spine-like structures.
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Figure 3.18: Translocation of endogenous CaM in rat hippocampal cultures (E18, 12
DIV) stained with anti-CaM antibodies. CaM translocates to the nucleus of neurons
following stimulation with 90 mM K+ for 180 s (see arrowheads).
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used only a small proportion of transfected cells had a detectable Cerulean signal,
which was primarily located to vesicles in the soma. Transfection ratios of 5:1 or
10:1 (rEAG1/CaM, m/m) resulted in detectable levels of rEAG1-Cerulean in neu-
rites.
FRET was measured by acceptor photobleaching in co-transfected, fixed neurons
stimulated with 90 mM K+ for 180 s or 1 µM ionomycin in Ringer (1.8 mM Ca2+).
In either case no interaction between rEAG1-Cerulean and Venus-CaM could be
recorded, both in neurites and in the soma of transfected neurons, at different trans-
fection ratios (Fig.3.19 ).
The ratio of fluorescently-labeled to endogenous CaM is lower in trans-
fected neurons than in HEK293 cells
CaM is expressed endogenously in high amounts in neural tissue. In order to verify
if the absence of measurable FRET in neurons was due to competition from non-
fluorescent endogenous CaM, the ratio of endogenous to transfected CaM was de-
termined in neuronal cultures co-transfected with rEAG1-Cerulean and Venus-CaM
and also in HEK293 cells co-transfected with the corresponding CMV promoter
constructs (Fig. 3.20).
Co-transfected cultures were stained with anti-CaM and antibodies and the average
intensities of this staining were compared for several regions of interest (for neurons:
both in the soma and neurites) in transfected and untransfected cells. Differences
between average intensities of the CaM staining were normalized to the average
intensity of CaM in non-transfected cells, in order to determine the ratio of Venus-
CaM/endogenous CaM. This was found to be 1.4 (±0.2 SEM) in transfected HEK
cells, but merely 0.2(±0.1 SEM) in neurons, meaning that the majority of CaM
present in transfected neurons is endogenous and unlabeled. Binding competition
from endogenous CaM is therefore likely to account for the fact that no FRET is
measurable between rEAG1-Cerulean and Venus-CaM in neurons.
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Figure 3.19: Acceptor photobleaching FRET measurements between rEAG1-Cerulean
and Venus-CaM in co-transfected rat hippocampal cultures (E18, 12 DIV). No FRET was
measured both in the soma and processes of co-transfected neurons, after stimulation with
90 mM K+ or 1 µM ionomycin in the presence of Ca2+. Neurons transfected with DNA
ratios of 3:1 (EAG1:CaM, m/m) had little or no detectable signal in neurites, allowing
measurements only in the soma (A). DNA ratios of 10:1 resulted in EAG1 being detected






































































































4.1 Photoconversion of Yellow Fluorescent Pro-
teins
A part of the present work describes the permanent photochemical conversion of
YFP to a fluorescent species (XFP) with an emission maximum of 470 nm, upon
‘photobleaching’ with 514 nm illumination. The emission maximum of the XFP pho-
toconversion product closely matches that of cyan fluorescent proteins, making it
difficult to separate the emission of both species and thereby interfering with accep-
tor photobleaching FRET measurements [4]. Acceptor photobleaching is a relatively
simple and cost-effective method of measuring FRET in a cellular environment, es-
pecially in intermolecular assays, because it is relatively free from constraints of
different donor/acceptor expression levels which frequently affect other intensity-
based FRET methods. Acceptor photobleaching experiments using the CFP/YFP
FRET pair (or their derivatives) [46] are one the most widely used FRET experiment
configurations, the artifacts arising from the photoconversion of YFP are therefore
of great relevance.
Yellow fluorescent proteins are long known to undergo intensity fluctuations (blink-
ing [47]) and reversible photobleaching [82] - fluorophores photobleached with 514
nm light spontaneously recover their fluorescence over hours or over seconds when il-
luminated in the 330-390 nm range. However, a complete spectroscopic study of the
photochemistry of YFP was only recently reported [42]. McAnaney et al. describe
the irreversible formation of a weakly fluorescent product upon prolonged illumina-
tion of YFP. This product (termed XFP) was found to have absorption and emission
maxima at 390 and 460 nm, respectively. This is compatible with the findings of
our work, in particular with the fact that the fluorescence emission of the photo-
conversion product was strongest upon 405 nm excitation (i.e., close to the 390 nm
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absorption peak of XFP) and much fainter under 458 nm illumination. Velentin et
al. [85] reported similar data, based on photobleaching experiments performed with
YFP and its derivatives Citrine and Venus.
The photoconversion of YFP and its derivatives should be considered when per-
forming photobleaching experiments. The photoconversion product XFP is weakly
fluorescent but can interfere with FRET measurements under specific circumstances,
namely whenever a high concentration of YFP is present. The concentration of YFP
will determine how much XFP is formed during photobleaching. Nevertheless, the
contribution XFP fluorescence to measured FRET efficiencies will depend on the
concentration of CFP, since relative increases in the fluorescence of the donor are
measured. Experiments where both proteins of interest are homogeneously expressed
in the cytosol are not likely to display effects of photoconversion (and this is prob-
ably why this process went so long unnoticed). However, if the donor is present in
small structures and the acceptor is cytosolic, as when measuring the interaction of
EAG with CaM, then there is a high probability that XFP fluorescence will affect
the measured FRET efficiencies.
The proportion of XFP fluorescence on the donor image can be kept to a minimum by
exciting CFP with a wavelength as far a possible from the 390 nm absorption peak of
XFP. Lately, 405 nm lasers have been promoted as a good alternative to the 458 nm
line of Ar lasers, which is relatively faint. However, our results show that 458 nm can
drastically reduce the excitation of the YFP photoconversion product (Fig. 3.3), and
are therefore more suitable for use in acceptor photobleaching FRET experiments.
Recently new solid-state 430 nm lasers have become available that would probably
be a good alternative to 458 nm. Despite being closer to the excitation maximum
of XFP than 458 nm, these lasers are able to optimally excite CFP which has an
absorption maximum precisely at 430 nm.
The CFP/YFP FRET pair was already known to have problems caused the low
brightness of CFP (see §1.2.1). The photoconversion of YFP now presents a further
disadvantage for the use of these chromophores. A large number of new fluores-
cent proteins has recently become available which are likely to finally render the
CFP/YFP pair obsolete. However, the photoconversion of yellow FPs could prove
to be useful in some cases, such as the possibility of using YFP as a highlightable
protein for tracking experiments. Though far from being a good alternative to
purpose-designed photoconvertible proteins such as Kaede [83], YFP-fusion pro-
teins are used in a many transgenic mice where the cost of cloning a new high-
DISCUSSION 55
lightable protein would probably outweigh the benefits. In cases where the intensity
of the photoconverted protein permits its tracking this possibility should not be
discarded.
In conclusion, FRET experiments using the CFP/YFP pair and their derivatives
should include a non-interacting control which is in all similar to the YFP-fused
protein but where no FRET is expected. In this work the CaM mutant with impaired
Ca2+ binding apoCaM was used. In experiments where photoconversion poses a
problem stringent thresholding of areas with low donor expression is recommended.
The different absorption maxima of XFP and CFP could potentially be used to
spectrally separate the two chromophores.
4.2 Mechanism of Ca2+/CaM inhibition of EAG
channels and potential functional implica-
tions
Several studies [8, 38] have suggested a role for EAG channels in the regulation of
neuronal excitability, possibly by contributing to the maintenance of the resting
membrane potential. EAG channels mediate inward-rectifying currents with activa-
tion close to the membrane resting potential which would be compatible with such a
physiological function. The dependence of the EAG currents on the holding voltage
(Cole-Moore effect) [38] and the regulation of their gating by extracellular Mg2+ [78]
give further support to this hypothesis.
Rat and human EAG1 were found to be inhibited by Ca2+ with a half-maximal
inhibition occurring at a Ca2+ concentration of ∼100 nM [74]. Schönherr et al. [70]
reported that this inhibition was mediated by the binding of Ca2+/CaM to the C-
terminus of the channel. Calcium levels are a good correlate of neuronal activity and
membrane depolarization. Ca2+-activated potassium channels (such as BK, IK and
SK) establish a negative feedback loop whereby depolarization-induced high Ca2+
levels activate re-polarizing K+ currents [75]. Interestingly, EAG channels close in
response to increases in Ca2+ just above the resting concentration, thus exerting a
positive feedback on neuronal activity.
The presence of these regulatory mechanisms must exert a tight control on the
activity of the channel. The Cole-Moore effect and the Mg2+ regulation hinder
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current activation after hyperpolarization whereas Ca2+ could inhibit the channel
during and following neural activity, during which Ca2+ levels are usually high.
Although these mechanisms of regulation have been studied, the actual physiological
function of EAG is not known. The inhibition of EAG1 currents by CaM at close-
to-resting Ca2+ concentrations is perhaps the factor that will most contribute to
the physiological function of the channel, as it is expected to severely limit its open
time.
The present work aimed at further understanding the Ca2+/CaM-mediated regula-
tion of EAG channels in order to obtain a an insight in its possible physiological
significance in neurons.
4.2.1 FRET assay for CaM binding to EAG
Expression of fluorescent fusion constructs of EAG
Membrane proteins, such as ion channels, usually display a characteristic membrane
contour staining when expressed as fluorescent fusion constructs or detected with
fluorescent antibodies. In the case of EAG1 such a membrane contour is seldom
visible. The channel is present predominantly in the cytosol in the form of small
vesicles. Both hEAG1 and especially rEAG2 are prone to form aggregates in the
ER/Golgi and perinuclear regions when expressed in mammalian cell lines. How-
ever, this is the case both for the wild-type channels as for their Cerulean-fusion
counterparts. Furthermore, the electrophysiological properties of the overexpressed,
fluorescently-labeled channels appear to be conserved.
Members of the EAG channel family have been shown to have an ER retention
signal of the RXR type [96]. This was first reported for hERG [33], where muta-
tion of the RGR sequence at aa. 1005-1007 results in larger current densities being
measured, reflecting a larger number of channels in the cellular membrane, which
was confirmed by a biotinylation assay for membrane expression. It has been pro-
posed that this ER retention signal prevents the Kir 6.1/2 and GABAB receptor
subunits from leaving the ER before they are assembled in a functional tetrameric
form [40, 96]. Conformational changes that occur upon tetramerization of the sub-
units would mask these signaling sequences, thus permitting the trafficking of the
channel to the membrane. In hEAG1 the RKR sequence at aa. 675-677 was mu-
tated (to LKL) and shown to increase current densities when expressed in Xenopus
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oocytes and HEK293 cells ( [26], L. Pardo, personal communication). However, the
expression pattern of the channel did not display significant changes in CFP-fusion
constructs containing the same mutations, an indication that the increase in channel
trafficking is not sufficient for visible changes in the fluorescence pattern to occur.
The data shown in this work was obtained with EAG constructs containing an intact
RKR signal.
One study [24] found that rEAG1 interacts with KCR1, a membrane protein that
facilitates the functional expression of rEAG1 channel. This raises the prospect that
regulatory subunits may play a role in the trafficking and membrane expression of
EAG channels.
Localization of EAG constructs in hippocampal neurons
When expressed in dissociated hippocampal cultures, rEAG1-Cerulean displays a
fluorescence pattern similar to that of HEK293 cells - no membrane countour stain-
ing, most of the fluorescent signal is present in small vesicles which concentrate
mainly in the soma and perinuclear region (Fig. 3.16). Channels expressed in neu-
rons have a smaller propensity to form aggregates in the ER/Golgi than in HEK
cells, however, this could be an effect of low expression under the hSyn promoter
and not necessarily cell-type related. Over-expressed rEAG1-Cerulean is present
throughout the transfected neurons, not only in the somatodendritic compartment
but also in axons. Whereas no endogenous rEAG1 could be detected with the 7194
antibody in hippocampal cultures, EAG2 appeared in both dendrites and MAP2
negative processes implying both axonal and dendritic localization.
There is presently a single published study on the subcellular localization of endoge-
nous EAG channels. Jeng et al. [25] found that EAG was present only in the somata
and dendrites of dissociated rat hippocampal neurons. In the same study the au-
thors localized EAG to the post-synapse. This result was based on the fact that
the stainings of EAG channels were present in MAP2 positive processes but did not
colocalize with the axonal marker Tau. Moreover, co-localization of both channels
with the synaptic marker p38, and of EAG1 with the glutamatergic post-synaptic
marker Densin and EAG2 with the GABA-ergic pre-synaptic marker GAD indicate
an excitatory synapse localization for EAG1 and inhibitory for EAG2. Neverthe-
less, it is questionable whether optical microscopy has the necessary resolution for
localizing ion channels to either pro- or post-synapse. The distance between both
synaptic terminals is about 20 nm [68], i.e., over ten times smaller than the res-
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olution of a confocal microscope. The authors argue that, should the localization
be pre-synaptic, transport vesicles would be visible in the axons. However, electron
microscopy would be a more direct assay for pre- or post-synaptic localization. A
yet unpublished electron microscopy study done in sections of adult rats has found
EAG1 to be present in the pre-synaptic terminals (M. E. Rubio, L. Pardo, personal
communication). Furthermore, antibody stainings of adult rat brain sections re-
vealed the presence of EAG1 in the Purkinje cell layer of the cerebellum but not in
the granule or molecular layers (S. Martin, F. Queiroz, personal communication). In-
situ hybridization studies have shown that mRNA coding for EAG1 is only present
in the granule layer and to a lesser extent in the deep nuclei of the cerebellum [39,66].
It is therefore likely that the EAG1 found in the Purkinje layer is actually present in
neurons establishing synapses onto Purkinje cells (in their proximal processes) and
consequently that it is localized in the pre-synapse.
This conflicting data shows that the intracellular localization of EAG is still unclear.
A synaptic localization seems consensual, although different studies suggest either
pre-synaptic or post-synaptic localizations. This question is, however, essential for
formulating any hypothesis on the function of EAG channels. The endogenous
distribution of EAG would also be needed in order to verify the distribution of
over-expressed rEAG1-Cerulean in hippocampal neurons.
CaM expression and translocation
Upon expression in HEK cells, fluorescent fusion-constructs of CaM and apoCaM
were present in the cytoplasm and nucleus, their concentration in the nucleus being
usually higher than in the cytoplasm (Fig. 3.5). The presence of CaM in the nucleus
is believed to be related to its function as activator of transcription factors [16,44].
CaM is transported to the nucleus by passive diffusion and by facilitated mechanisms
which can be both Ca2+-dependent and -independent [79]. Active transport is also
seems to play a role in the nuclear transport of YFP-CaM and YFP-apoCaM, given
that the nuclear concentration of both proteins is frequently higher than in that of
the cytoplasm.
Expression of CaM constructs in neurons
In rat E18 hippocampal cultures (10-12 DIV) both CaM and apoCaM fusion con-
structs displayed a homogeneous cytosolic localization in the somatodendritic com-
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partment and axons (Fig. 3.17). Endogenous CaM is known to be expressed in
all neural tissue at all ages [91], although its intracellular localization varies during
development [11]. It is present at highest concentrations in the soma and dendrites
of neurons.
CaM is known to translocate to the nucleus of neurons in response to synaptic
inputs. Translocation to the nucleus occurs upon Ca2+ entry through post-synaptic
L-type channels and NMDA receptors [16]. This effect can be induced in neuronal
cultures by applying a depolarization pulse with 90 mM K+ for 180 s [16] and could
be reproduced under our culture conditions (E18 rat hippocampus, 10-12 days in
vitro).
In transfected neurons, the concentration of fluorescent CaM is lower in the nucleus
than in the surrounding cytoplasm. Moreover, no significant translocation of CaM
is seen upon depolarization (Fig. 3.17). Paradoxically, apoCaM was present at
the same concentration in both nucleus and cytoplasm. Again, no translocation of
apoCaM is seen upon stimulation. The fact that apoCaM is present in equal amounts
in nucleus and cytoplasm could be explained by passive diffusion or transport by
Ca2+-independent mechanisms. The concentration of free apoCaM is expected to
be far larger than that of CaM. This is because the latter tends to have more
binding targets than the former. However, it is surprising that Venus-CaM did not
translocate in a larger scale to the nucleus after a 180 s depolarization pulse, as
reported by Mermelstein et al. [44].
Another feature of CaM-transfected neurons was their strikingly increased neuritoge-
nesis and branching (Fig. 3.17). CaM is known to promote neuritogenesis through
a molecular pathway involving CaM-dependent kinases (CaMK) I and II [23, 90].
The availability of CaM is often a rate-limiting step in many reactions it cataly-
ses [36, 57, 63], which raises the possibility that CaM overexpression leads to mor-
phological changes in neurons.
Neurons transfected with Venus-CaM display an apparent increase in the number
of spines and filopodia upon stimulation. Dendritic spines are actin-rich and highly
motile structures [19, 22, 30] that contain the majority of post-synaptic densities in
hippocampal neurons. It is known that CaM has a role in the changes of size and
morphology of dendritic spines which take place after synaptic stimuli. Several stud-
ies have shown that these morphological changes are triggered by CaMKII [56,64,65].
Jourdain et al. [27] have shown that the rate of spine formation in hippocampal neu-
rons was increased upon injection of CaM and that this effect was not present when
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CaM was co-injected with a specific inhibitor of CaMKII. However, although changes
in spine shape can occur within seconds, spine volume changes and spine creation are
processes which usually take a few minutes and up to one hour [56]. The increase in
the number and size of fluorescent spines in neurons expressing Venus-CaM is there-
fore likely to be linked to the relocation of CaM/CaMKII complexes to dendritic
spines [72]; i.e., the major change is in the concentration of Venus-CaM in spines
even though small changes in volume and shape of the spine may occur.
Co-expression of EAG and CaM/apoCaM fusion constructs
One of the first steps in the design of a FRET experiment is the assignment of donor
and acceptor fluorophores to the proteins being studied. When measuring FRET by
acceptor photo-bleaching [4] only the intensity changes of the donor fluorophore are
used for computing FRET efficiencies (see Eq. 1.4). Unbound donor molecules can
hence reduce the apparent FRET efficiency. The stoichiometry of the interaction
will therefore affect FRET efficiencies - more acceptor molecules per donor results in
higher FRET efficiencies, as the probability of energy transfer is higher. Schönherr
et al. [70] proposed that one CaM molecule is sufficient to block hEAG1, assuming
that only one or possibly two CaM molecules would bind to the channel, a highly
favorable 1:4 or 1:2 donor:acceptor ratio would be achieved labelling CaM with
Cerulean and hEAG1 with YFP. However CaM is a cytosolic protein expressed in
higher amounts and with a more disperse cytosolic pattern than hEAG1, changes in
Cerulean fluorescence due to FRET are therefore bound to be diluted in the total
CaM signal. Labeling hEAG1 with Cerulean permitted the measurement of FRET
with YFP-CaM as acceptor.
For FRET experiments with fluorescently labelled EAG and CaM donor and accep-
tor constructs were co-transfected in different ratios. An excess of acceptor molecules
is desireable for an increased probability of energy tranfer. This is usually achieved
by transfecting more acceptor cDNA than donor. This approach was tried for dif-
ferent EAG:CaM transfection ratios but instead a mass excess of donor cDNA was
found to be beneficial for FRET measurements. In this study the nature of the pro-
teins of interest is significantly different - EAG is a 962 aa. long membrane protein
that undergoes post-translational assembly and glycosilation [52] and CaM is a much
shorter (148 aa.) cytosolic protein. Therefore production of EAG in cells is sub-
stantially slower than CaM and, in addition, EAG was labeled with a much fainter
fluorophore. This resulted in low and noisy donor signals. The best donor:acceptor
DISCUSSION 61
(m/m) transfection ratios were found to be 3:1 for HEK cells and 10:1 for neuronal
cultures.
Ratio of endogenous to overexpressed CaM in neurons
FRET experiments performed in cells that endogenously express one of the inter-
acting proteins face the additional problem of competition from unlabeled binding
partners. This was found to occur in neurons co-transfected with Cerulean-fused
rEAG1 and Venus-labeled CaM. CaM is one of the most abundant proteins in neu-
rons, the ratio of fluorescently-labeled to endogenous CaM is only 0.2 in transfected
hippocampal neurons whereas in HEK293 cells it is 1.4 (Fig. 3.20). Endogenous
CaM is therefore more abundant and competes for binding with EAG1, thereby
reducing the amount of molecules available for FRET. Since neurons are sensitive
to protein overexpression, increasing the total amount of transfected DNA is not
a viable solution, while increasing the proportion of transfected CaM to EAG1 is
likely to result in the EAG Cerulean signal no longer being detected. A further
disadvantage of overexpression of CaM is that small changes in CaM concentration
will lead to large changes in the Ca2+-buffering of neurons, possibly leading to un-
physiological situations. Using a fluorescently-labeled CaM antibody as a FRET
acceptor would permit the measurement of FRET between endogenous CaM and
fluorescent EAG, thus circumventing the problems of overexpression.
In order to measure FRET between EAG and genetically-labeled CaM in neurons
the endogenous levels of EAG should be lowered or a CaM YFP knock-in mouse
used. At present no fluorescent CaM transgenics have been reported. CaM is
encoded in mammals by three genes (CaM1, CaM2, CaM3) which are concurrently
expressed in most areas of the brain [58]. This poses a considerable challenge to
the suppression of endogenous CaM by RNA interference, which could be aimed at
the 5′ untranslated region of CaM mRNA so that the expression of the YFP-labeled
construct is not affected.
Alternatively, a concatenated construct joining Cerulean-labeled rEAG1 and Venus-
CaM would enable the maintenance of a constant high local concentration of labeled
CaM (see Mori et al. [50] for a similar approach). Such a construct would be good at
sensing changes in Ca2+ concentration but less good for changes in the availability
of CaM.
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4.2.2 N-terminal CaM binding domain of EAG1 chan-
nels
hEAG1 channels were previously known to be inhibited by Ca2+/CaM. Mutations
in the CaM binding site at aa. 707-726 were found to prevent the binding of CaM
to the C-terminus domain and consequently to prevent the inhibition of hEAG1 by
CaM [70]. The FRET assay described in the present study found that the interaction
of the C-term-rEAG1 with CaM could be fully inhibited by Ca2+ depletion whereas
the same treatment merely reduced the interaction of CaM with the full-length
hEAG1 (Fig. 3.5).
The differences in Ca2+-dependent binding of hEAG1 and the cytosolic C-terminus
domain of rEAG1 could be due to a steric loss of function of the truncated protein
(i.e. due to the destruction of intramolecular interactions) or due to the presence
of further CaM-binding domains. It is less likely that any differences observed are
due to distinctions in the aminoacid sequence of the two species. Rat and human
EAG1 share 98 % of their sequence and the same FRET assay done with rEAG1
revaled the same Ca2+ response (data not shown). However, as mentioned above,
the rat variant of EAG1 was found to be largerly retained in the ER and Golgi
apparatus.
The C-terminal CaMbd mutations described by Schönherr et al. [70] were found
to abolish the binding of CaM to the C-terminus of EAG1 but not to the full-
length channel (Fig. 3.6). The FRET efficiencies measured for the mutated full-
length channel were approximately the same under high and low Ca2+ conditions,
which is strongly indicative of the presence of a second binding domain with higher
affinity for Ca2+/CaM, at a site outside of the C-terminal tail. No interaction
was found between apoCaM and EAG1, showing that the channel does not bind
Ca2+-free CaM. Furthermore it is unlikely that the steric effects could account for
the abolition of the CaM interaction in the truncated C-terminus containing the
CaMbd mutations: Schönherr et al. have found that the KD of the binding of CaM
to the segment 673-867 of hEAG1 was compatible with the half-maximal inhibition
of ∼100 nM found in electrophysiology studies, assuming the binding of one molecule
of CaM to each channel tetramer is sufficient for current inhibition [70].
A CaM binding domain was found to be present in the N-terminus of EAG1. An
overlay blot assay found direct binding of CaM to the segment aa. 147-209 of EAG1
(Fig. 3.8), while mutations F151S, A152S in this segment have localized the binding
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to a 1-8-14 CaM binding motif at aa. 151-164 (Fig. 3.9). This type of CaM binding
motifs usually only interact with Ca2+-bound CaM and have high binding affinities
[60]. That is compatible with the finding that CaM binding to EAG is detected even
under low Ca2+ conditions. Channels containing both N- and C-terminal CaMbd
mutations were found not to interact with CaM, as no FRET could be measured
between both constructs, meaning that these two binding sites are essential for the
binding of CaM to EAG1 channels (Fig. 3.10). Other parts of the channel may
influence CaM binding to these primary sites, for example the aa. 668-679 sequence
of the C-terminus which was found to have a structure favorable to CaM binding in
the in silico screening (see 3.2.1).
A newly published study by Ziechner et al. [99] found evidence for the binding of
CaM to the 1-8-14 motif in the N-terminus (aa. 151-165), thus confirming the ex-
istence of this second CaM binding domain. A peptide array scan also found the
binding of CaM to the segments aa. 674-683 and 711-721, both in the C-terminus of
the channel. These segments correspond to the putative binding domain found in
silico and to the previously reported C-terminal CaMbd [70]. The same work was
nevertheless inconclusive about the ability of the newly found C-terminal segment
to bind CaM. Binding was found in the peptide scan and by confocal Fluorescence
Correlation Spectroscopy (FCS) using a short (∼20 aa.) peptide. Moreover, chan-
nels with mutations in this putative binding region showed some reduction in current
inhibition by Ca2+/CaM. However, a FCS study using longer GST-fusion segments
found no binding to CaM, the authors therefore speculate that this site is unable
to bind CaM independently. This view is supported by our data which shows that
no CaM binding occurs when the other two sites are disrupted by mutations (Fig.
3.10).
Ziechner et al. [99] found that both N- and C-terminal CaM binding sites were
essential for the inhibition of hEAG1 currents by Ca2+/CaM, as mutations in either
site impaired Ca2+-driven current reductions. The relative CaM affinity of both sites
was not entirely clear - the N-terminus (aa. 1-206) was found to have approximately
the same binding affinity for Ca2+/CaM as the C-terminus (aa. 649-867) in FCS
and Surface Plasmon Resonance (SPR) studies. However, when the FCS assay was
repeated with short peptides the N-terminus, CaMbd was found to have a higher
affinity than that of the C-terminus (KD = 45 and 223 nM, respectively). Our data
is clearly in favor of the latter situation: the N-terminus binding domain was found
to interact with CaM even in Ca2+-depleted cells, reflecting a higher affinity than
that of the C-terminus.
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The present study therefore confirms and disambiguates the data of Ziechner et al.,
thereby highlighting the potential of FRET for the study of molecular interactions.
Whereas FRET measurements were performed in a cellular environment with the
membrane-inserted channels in their native state, biochemical and FCS assays used
segments of channel subunits, the length of which was shown to affect the experi-
mental outcome. Nevertheless, there is conclusive evidence from both studies for the
presence of a further CaM binding domain in the N-terminus part of hEAG1.
4.2.3 Molecular model of EAG1 inhibition by CaM
The molecular model of the interaction of hEAG1 and CaM is currently facing a
revision, following the discovery that CaM needs to bind to both N- and C-terminus
for current inhibition to occur. The N-terminus of EAG channels is thought to play
a role in channel gating, as mutations and deletions of this sequence cause changes
in current activation and deactivation [77]. In fact Ziechner et al. [99] reported that
mutations in the N-terminal CaMbd resulted in more positive activation voltages.
Work by Terlau et al. and Morais-Cabral et al. [10,77] suggests that the N-terminus
may interact with the S4-S5 intracellular linker of the EAG-family channels, which
is itself thought to be involved in channel gating.
The mechanism of CaM inhibition of EAG appears to be substantially different to
that of Ca2+-activated potassium channels, which have been shown to constitutively
bind CaM independently of Ca2+ concentration (see [67,75] for a review). However,
two channel families with structural and functional similarities to EAG were also
found to contain CaM binding domains, namely Cyclic Nucleotide Gated (CNG)
[81,92] and KCNQ channels [93,95].
Potassium channels of the KCNQ family have several similarities with EAG, both
in terms of structure and electrophysiological properties. In fact, both channels
have been proposed as mediators of the M-current, a low-voltage threshold potas-
sium current which is inhibited by muscarinic acetylcholine and other receptors [73].
KCNQ channels have been shown to constitutively bind CaM through an IQ-like
CaM binding motif [60], CaM bound to the channel in this manner was shown to
mediate the inhibition of the channels by Ca2+. The mechanism of Ca2+/CaM reg-
ulation of these channels is therefore different from that of EAG channels, despite
their structural and electrophysiological similarities.
CNG channels are the closest structural relatives of the EAG channel family. They
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share several structural features with EAG including a cyclic-nucleotide gating do-
main, that, although partially conserved from a sequence point of view, was found
not to be functional in EAG1. In CNG channels, a CaM binding domain was
shown to be present in the N-terminus of CNGB1 subunits and to mediate an in-
tersubunit interaction with the C-terminus of CNGA subunits [92]. CaM in its
Ca2+-associated form has been shown to bind to the CaMbd of CNGB1, thereby
disrupting the intersubunit interaction and inhibiting the channel [81]. In order to
verify if such an inhibition mechanism is present in EAG1 (Fig. 4.21) the bind-
ing of N- and C-terminus was tested on an overlay blot both in the presence and
absence of Ca2+/CaM (data not shown). In both cases, no interaction between
both intracellular domains could be recorded. This was is in accordance with the
results of Ziechner et al. [99], who could not find an interaction between N- and
C-terminal protein fragments of hEAG1 in precipitation assays. However, low affin-
ity interactions can be difficult to detect using standard biochemical methods. Ion
channels are highly dynamic structures that can have large conformational changes
between open and closed states. These structural subtleties are irreproducible in
many biochemical assays. Preliminary FRET data, obtained with fluorescent fusion
constructs of both cytosolic termini indicates that an interaction could potentially
occur. A FRET assay for conformational changes of olfactory CNG channels was
reported by Zheng et al. [97] and allows the monitoring of the distance between in-
tracellular domains of the channel with simultaneous electrophysiological recordings
under different Ca2+ concentrations. The same approach could potentially be used
to elucidate the molecular mechanism behind Ca2+/CaM ihibition of hEAG1.
The presence of two CaMbd in hEAG1 subunits also suggests that both N- and
C-terminal binding domains could bind one single CaM molecule, thereby inducing
a conformational change of the channel. This seems unlikely, as Ziechner et al. [99]
found that both N- and C-terminal CaMbd both bind to the C-lobe of CaM, contain-
ing EF-hand domains 3 and 4, indicating that probably up to eight CaM molecules
can bind to the channel. This is supported by the high FRET efficiencies measured,
even in the presence of competition from endogenous CaM in HEK cells.
The N-terminus was found to have a very high affinity for Ca2+/CaM (KD = 45
nM Ca2+ in one estimate [99]), raising the prospect that CaM could be a nearly-
permanent constituent of hEAG1 channels. This is however dependent on the local
concentrations of Ca2+ and availability of CaM to the channels, further highlighting
the importance of the channel localization for modeling the function of EAG1.
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Figure 4.21: Schematic representation of a possible cooperative mechanism of N- and
C-terminus for activity regulation of EAG, in which an interaction between both cytoso-
lic termini is disrupted by the binding of Ca2+/CaM. This hypothesis is in analogy to
intersubunit interactions in CNG channels where the cytosolic N-terminus binds to the
C-terminus in the region of the cyclic nucleotide binding domain.
4.2.4 EAG localization, inhibition and function
The interaction with Ca2+/CaM appears to be, a par with its voltage sensitivity,
the dominant mechanism of EAG current regulation. The concentration of Ca2+
near the membrane can be extremely heterogeneous, in particular in the vicinity
of Ca2+-channels [5, 48] and, therefore, small differences in localization can have a
large impact on EAG currents.
The simplest functional mechanism of action of EAG channels would be one where
an increase in Ca2+ inhibits EAG currents, thereby facilitating depolarization. EAG
would then act as a Ca2+ sensor, repressing depolarizations which are not accom-
panied by an increase in Ca2+ concentration. The task of repolarizing the cell
would then be left to other (e.g., delayed rectifier) channels. However, given that
the Ca2+/CaM inhibition occurs so close to the resting Ca2+ levels, one would ex-
pect either limited channel activity or a specific localization away from Ca2+ chan-
nels.
Ca2+ regulates EAG through CaM, a molecule that, although abundant, has nu-
merous binding partners, some of which are permanently bound with high affinity.
A situation where competition for CaM underlies the regulation of EAG is there-
fore not to be excluded. It has been suggested that CaM can be locally depleted
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under certain circumstances [57]. Though speculative, a mechanism of local CaM
depletion is supported by other examples of rapid CaM translocation, e.g., to the
nucleus [16] or to spines [72]. Should activity/Ca2+-induced competition for CaM
be present, open EAG channels would be able to counter mounting neuronal ac-




Several studies [8, 38] have suggested a role for EAG channels in the regulation of
neuronal excitability, possibly by contributing to the maintenance of the resting
membrane potential. EAG channels mediate inward-rectifying currents with activa-
tion close to the membrane resting potential which would be compatible with such
a physiological function. Knowledge on the regulation of the activity of this kind of
channels is therefore potentially important for the study of neuronal signaling.
EAG1 has been known to be inhibited by intracellular Ca2+ with a half maximal
concentration of 100 nM and this inhibition has been shown to be mediated by direct
binding of calmodulin (CaM) to the C-terminal domain (aa. 707-726) of the channel
[70]. The regulation of EAG activity was studied by visualizing its interaction with
CaM, using an intermolecular FRET approach. FRET was measured between YFP-
labeled CaM and several Cerulean-labeled EAG constructs. The fusion-proteins
were expressed in HEK cells and the interaction was found to be Ca2+-dependent as
the FRET efficiency decreases with increasing Ca2+ concentrations and is abolished
when using a Ca2+-insensitive CaM mutant.
Mutations in the previously described CaM binding site at aa. 707-726 were found to
prevent the binding of CaM to the C-terminus domain and consequently to prevent
the inhibition of hEAG1 by CaM [70]. The FRET assay described in the present
study found that the interaction of the C-term-rEAG1 with CaM could be fully
inhibited by Ca2+ depletion, whereas the same treatment merely reduced the in-
teraction of CaM with the full-length hEAG1. This interaction was found to be
accounted for by the presence of a further, high affinity CaM binding domain in the
N-terminus of the channel at aa. 151-164.
In conclusion the present results show that two CaM binding sites are present in
hEAG1 subunits - a high-afinity CaM binding domain of the form 1-8-14 in the
N-terminus and the previously described C-terminal binding domain at aa. 707-
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276. Mutations at these sites lead to the complete disruption of CaM binding to
the hEAG1, these two binding domains are therefore responsible for CaM binding.
These findings indicate that the regulation of hEAG1 by Ca2+ /CaM is more complex
than previously thought.
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